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Lactobacillus reuteri DSM 17938 is a probiotic bacterium manufactured by the company 
BioGaia AB and was in focus of this study. If a probiotic product is to confer its beneficial 
health effect to a consumer, it must retain high viability levels during long-term storage. A 
common practice for conservation of living microorganisms to meet this criterion is freeze-
drying. Freeze-drying of bacteria is a process dependent on many factors and needs to be 
carefully designed in order to be successful. Preconditioning the bacteria before freeze-
drying by subjecting them to different conditions during cultivation is one of the ways 
toward optimizing the survivability of freeze-drying and subsequent storage-stability. In 
theory, finding more robust mutants of L. reuteri could be yet another way of reaching this 
goal. It has been discovered that at least in some species of bacteria, increasingly resilient 
generations of mutants arise in consecutive waves during prolonged batch cultivation and 
are referred to as “growth advantage in stationary phase” (GASP) mutants. 
The overall goal of this study was to work towards a viable and storage-stable product 
based on L. reuteri. The first objective was to investigate if survival of a freeze-thaw assay, 
in which differently preconditioned L. reuteri are subjected to cycles of freezing and thaw-
ing, correlates with storage-stability. This could verify the potential use of the freeze-thaw 
assay instead of performing slow and laborious long-term stability studies when optimiz-
ing the production process, as well as provide insights into which cultivation conditions 
confer the highest storage-stability. A second objective was to investigate prolonged batch 
cultures of L. reuteri as a hypothetical source of GASP mutants. It was further hypothe-
sized that appearance of GASPs would be detectable by isothermal microcalorimetry. 
L. reuteri was cultivated at different settings of pH and temperature and freeze-dried in a 
15% w/v sucrose formulation. Survival of the freeze-thaw assay and an accelerated storage 
assay at 37 °C were compared by viable counting and subsequent ANOVA and Tukey’s 
test. This was complemented by microscopic morphology and Gram-stain studies. For the 
mutant-related experimental objective, L. reuteri and E. coli (as a control organism) were 
cultivated for up to 70 days while their heat production was measured in isothermal micro-
calorimeters (IMC). 
A consistent inverse correlation was found between the freeze-thaw assay and the accel-
erated storage assay. High pH, and to a lesser extent, high temperature were associated 
with higher stability but lower freeze-thaw assay survival. Microscopic studies did not find 
any consistent association between stability and morphology except for the absence of cell 
clumps in the most storage-stable case. No GASP-revealing heat flows could be observed, 
neither with L. reuteri or E. coli controls. The collected data implied that L. reuteri did not 
produce GASP mutants. Future effort is suggested to be put into finding out if survival of 
the freeze-drying and subsequent storage-stability can both be improved independently and 
in such case, separate assays for both criteria should be employed. In conclusion, it is like-
ly that the causes for differences in storage-stability and freeze-thaw survival reside in 
biomolecular phenomena affected by cultivation conditions. IMC does not seem to be a 
Abstract 
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feasible tool for GASP detection; the possible reason could be lack of agitation and thereby 
no GASP growth. However, IMC devices with stirring could still be evaluated as a tool for 
GASP detection. 
Keywords: freeze-drying, lyophilization, Lactobacillus reuteri, storage stability, survival, 
freeze-thaw, morphology, microscopy, long-term stationary phase, GASP, isothermal 
microcalorimetry, probiotic, fermentation, preconditioning  
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General abbreviations 
ANOVA Analysis of Variance 
CI Confidence Interval 
CFU Cell Functional Unit  
CV Coefficient of Variation  
EMM Estimated Marginal Mean 
FT-assay Freeze-Thaw assay 
GASP Growth Advantage In Stationary Phase (a mutant type) 
IMC Isothermal Microcalorimetry  
LB Luria-Bertani growth medium 
MOPS 3-(N-morpholino)propanesulfonic acid buffer 
MODDE “Modeling and design” – a statistical software 
MRS De Man, Rogosa and Sharpe growth medium 
MSE Mean Square of the error 
OD Optical Density 
SPSS A statistical software 
Tc Collapse temperature of an amorphous glass phase into a viscous 
phase 
Tg’ Glass transition temperature of the bacteria-formulation precipi-
tant left after freezing of the water. The precipitant forms the 
amorphous glass phase at and below this temperature. 
Tukey-HSD Tukey’s Honest Significant Difference 
VC Viable Count 
Abbreviations 
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Experimental designs 
CRD Completely Randomized Design 
RCBD Randomized Complete Block Design 
RIBD Randomized Incomplete Block Design 
BRIBD Balanced Randomized Incomplete Block Design 
Treatments 
A 37 °C, pH 4.5 
B 32 °C, pH 4.5 
C 32 °C, pH 6.5 
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1.1 Importance of the topic 
Science is just beginning to unravel the complex and important roles of microor-
ganisms beneficial for our health. Those microbes that have a scientifically docu-
mented beneficial health effect are called probiotics and many probiotic products 
are already available commercially in forms of pills and dairy products. One such 
probiotic bacterium is Lactobacillus reuteri, on which this study focused. The 
Swedish company BioGaia AB is specialized in L. reuteri and its use for 
healthcare. The strains currently being sold are the original DSM 17938 in oral 
and gut health products and ATCC PTA 5289 and ATCC PTA 6475 in oral health 
products. The company is research-intensive and the strains are researched at insti-
tutions all over the world, part of the research is initiated by BioGaia and part is 
initiated independently. This study was done in collaboration with BioGaia and 
SLU as part of a project involving the design of a good production process for the 
probiotic. 
1.2 Problem formulation 
An important problem that must be tackled when making a probiotic microorgan-
ism into a commercial product is its storage-stability. This means that the cells 
must stay alive for a long time, because only viable cells can replicate in the gut 
and much of the health effects lies in the actions of live microbes. By carefully 
drying bacteria to a so called bacterial “powder”, their metabolism may be put to a 
halt without killing them and the degradative chemical reactions become slowed 
down; these are important prerequisites for stability (Béal & Fonseca, 2015). 
There are a few different methods for drying bacteria, however, this study focused 
on the freeze-drying method which is efficient and may lead to high survival rates 
1 Introduction 
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and good long-term viability of the product, when properly optimized (Meng et al., 
2008; Schoug & Åsa, 2009).  
Freeze-drying relies on the sublimation of ice which is accomplished by very 
slow heating-up of frozen bacterial samples in a vacuum environment. However, 
freeze-drying can be a harsh process for the bacteria. That is why the freeze-drying 
needs to be carefully designed and controlled to protect the bacteria from its dan-
gers, if high survival rates are to be achieved. To shield the bacteria from the dan-
gerous conditions which arise during freeze-drying, the bacteria are “formulated” 
in protective agents. Besides choosing the right formulation, the freeze-drying 
survival can be influenced by preconditioning the bacteria (Palmfeldt & Hahn-
Hägerdal, 2000; Koch et al., 2008; Meng et al., 2008; Schoug et al., 2008; Liu et 
al., 2014). Preconditioning may be done by for example using different settings 
during cultivation of the bacteria which alters the molecular profile of the cells. 
Therefore, it is hypothetically possible that the storage-stability could also be af-
fected by preconditioning. Additionally, which species of microbe is chosen has a 
crucial effect on freeze-drying survival and storage-stability (Schoug & Åsa, 2009) 
and so, potentially, may be choosing the right strain or finding the right mutant. A 
specific type of resilient mutants called “growth advantage in stationary phase 
mutants” (GASPs) has been discovered to evolve in some species of bacteria, dur-
ing prolonged cultivations (Zinser & Kolter, 2004; Finkel, 2006; Bačun-Družina et 
al., 2011). Whether GASPs mutants can appear in L. reuteri had not been re-
searched before this study. 
1.3 Aim and scope of study 
The overall aim of this study was to contribute to BioGaia’s project on finding a 
recipe for a viable and storage-stable product based on L. reuteri DSM 17938. The 
study built upon what was known from literature and the supervisor’s previous 
experience, such as which regimes are useful for freeze-drying. It also partly built 
upon some things that others involved in the project had investigated previously, 
such as the survival of a freeze-thaw (FT) assay. In the FT assay, explained in 
detail in section 3.1.4, the cells are subjected to repeated cycles of freezing and 
thawing. Depending on how the cells were preconditioned during cultivation, the 
survival ratios of this assay differed in previous investigations (Garcia, Armando 
Hernández et al., unpublished). 
As the first objective of this thesis, it was investigated whether survival of the 
FT assay could be correlated with the survival of freeze-drying and the subsequent 
storage-stability (depending on previous preconditioning by cultivation settings). 
This could potentially simplify future studies since the FT assay is much quicker 
9 
 
and much less work and resource intensive than direct measurement of storage-
stability. Additionally, microscopy was introduced to investigate if bacterial mor-
phology can be used as another predictor of storage-stability. Furthermore, these 
experiments would give some insight about which type of preconditioning gives 
the most storage-stable biomass. Whether preconditioning would produce differ-
ences in storage-stability was unknown; little research has been done around this 
subject (Yao et al., 2008; Velly et al., 2014). 
The second objective involved the strategy of looking for more resilient mu-
tants of L. reuteri. A hypothesis in this part of the study was that L. reuteri would, 
like some other bacteria, produce the resilient GASP mutants which could poten-
tially prove to be more tolerant to freeze-drying and storage. The supervisors had 
previous experience with the use of isothermal microcalorimetry (IMC), a sensi-
tive method which can measure the heat production of bacterial activity, elaborat-
ed in section 2.5. Therefore, it was further hypothesized that the emergence of 
GASP cultures could be detectable by IMC (something never investigated previ-
ously). 
The first objective of this study (correlation of FT-assay), was originally sup-
posed to be a small experiment with very simple statistics applied, while the main 
study would have been a small fractional factorial design using the design of ex-
periment software ”MODDE Pro” (Umetrics™) to find a good formulation for 
freeze-drying. Unfortunately, since there were a lot of technical problems at the 
correlation experiment, it took a while to gather enough data to biologically repli-
cate it and there was no more time for the formulation experiment. However, since 
statistics were supposed to be a major part of this thesis, a big effort was made to 
find a statistical approach applicable to the correlation experiment, as a practice in 
statistics. The statistical approach, which is well elaborated in section 2.6, took the 
path of block designs and ANOVAs (Analysis of Variance) with data transfor-
mations, largely by the aid of the statistical software IBM SPSS Statistics® (in 
short SPSS). 
1.4 Limitations 
There are other useful methods for drying bacteria: spray-drying or vacuum drying 
(Meng et al., 2008) and fluidized-bed drying (Albadran et al., 2015). However, 
these were left out of the scope. Other things left out of scope, besides investigat-
ing the effects of different formulations, were how the different cultures of L. reu-
teri tolerate gastric juices and if their beneficial interaction with host gut is re-
tained. Furthermore, to fully optimize the cultivation conditions in order to get the 
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most robust and storage-stable cells, bigger factorial experiments would be needed 
than what was done here. 
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2.1 Lactobacillus reuteri 
Many species of Lactobacillus are beneficial for a healthy gut by complex mi-
crobe-host and microbe-microbe interactions (Hammes & Hertel, 2006). A few 
Lactobacillus species (L. reuteri, L. salivarius, L. ruminis, L. gasseri and L. cris-
patus) are indigenous in the average human gut microflora, others are transient 
guests whose presence can fluctuate over time, yet may have important roles 
(Hammes & Hertel, 2006). Some of the simplest beneficial effects of Lactobacil-
lus species are the lowering of pH and the occupation of space and nutrients in the 
intestines, which prevents pathogenic microbes from settlement and growth 
(Hammes & Hertel, 2006).  
Lactobacillus reuteri is a Gram positive, rod-shaped bacterium and is a com-
mon component of the microbial flora of humans and many other animals (Ham-
mes & Hertel, 2006). It is obligately heterofermentative, meaning that instead of 
producing mainly one fermentation product (as in homofermentative), it produces 
a mixture of CO2, lactic acid, ethanol and/or acetic acid in equimolar amounts 
(Hammes & Hertel, 2006). Using the strain ATCC 55730, it was shown that  
L. reuteri does not produce acetic acid when grown in glucose as the carbon 
source (Årsköld et al., 2008). Furthermore, L. reuteri produces a bacteriocin  
(reutericin 6) and a bacteriocin-like inhibitory substance called reuterin (Hammes 
& Hertel, 2006). These substances inhibit many pathogenic microorganisms (in-
cluding fungi and protozoa) (Hammes & Hertel, 2006). Except for inhibiting path-
ogens, L. reuteri strains produce vitamins and essential metabolites from which the 
host can benefit and can also modulate the immune system of the host in different 
ways (Saulnier et al., 2011). There is a large genetic variability between the many 
different strains of L. reuteri: there are groups of specialized strains belonging to 
2 Background 
12 
 
specific hosts and there can be large variation between the strains (and their health 
effects) belonging to a single host species, such as humans (Saulnier et al., 2011). 
Beneficial effects of L. reuteri strains against gastrointestinal disorders of chil-
dren and infants has been shown in several clinical studies, it has also been proven 
to suppress some gastrointestinal infections and is proposed to prevent “leaky gut” 
(Saulnier et al., 2011; Pallin et al., 2015). There are also indications that it may be 
beneficial in the combat of allergic diseases (Clinical studies and meta-analyses | 
BioGaia). 
2.2 Freeze-drying of Lactobacillus 
Although water is essential to all known life, some forms of life can sustain at 
surprisingly dry conditions; this is studied in the field of anhydrobiotics. Because 
the anhydrobiotic condition stops the cellular metabolism and can under the right 
circumstances slow down surrounding chemical reactions extremely, it is a useful 
concept for enhancing longevity of cellular products (Béal & Fonseca, 2015).  
The goal of freeze-drying bacteria is to stabilize them in a viable, easily stora-
ble form of a well-dried “powder” with minimal water content and possibly in an 
amorphous glass state (Fonseca et al., 2015). Formation of an amorphous glass-
state matrix by a phenomenon called vitrification is beneficial for freeze-dry sur-
vival and subsequent storage-stability of cells (Schoug, 2009). Lyoprotectants such 
as disaccharides have a good ability to vitrify when exposed to a temperature be-
low the glass transition temperature (Tg’) during their rapid precipitation out of the 
aqueous solution when the water is forming ice crystals (Schoug, 2009). The water 
content of the precipitant affects the Tg’ strongly; less water gives a higher Tg’ 
(Schoug et al., 2010). There is also evidence of beneficial vitrification taking place 
within the cells themselves before the surrounding matrix vitrifies (Clarke et al., 
2013).    
Freeze-drying of Lactobacilli is composed of three main steps: First, the bacte-
rial samples are frozen down at a low temperature below the Tg’ of the formula-
tion, typically -50 or -80 °C, the water forms ice crystals while the precipitant of 
bacteria and formulant forms the amorphous glass phase (Fonseca et al., 2015). 
Then comes the primary drying step during which the pressure is kept very low 
and the shelf temperature is increased, usually to -20 °C to enable sublimation of 
the frozen water (Fonseca et al., 2015). The sublimated water is captured at an 
even colder part of the freeze-drier called the “cold trap”. However, the product 
temperature must not be increased above the collapse temperature (Tc), otherwise 
the amorphous glass phase collapses into a viscous phase. The pressure used does 
not influence Tc much directly (Fonseca et al., 2004a). However, the lowered pres-
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sure enables the sublimation which cools the samples; low pressure also lowers the 
surrounding temperature by removing most gas molecules (Jennings, 1999). Also, 
as the water sublimates and the product’s water content decreases, the Tg’ increas-
es and higher temperatures without collapsing become available. Lastly, comes the 
secondary drying step or the “step up” during which temperature is gradually in-
creased up to between 20 to 30 °C, this makes the last residual water to evaporate. 
This water was never a part of the ice crystals and therefore could not sublimate 
during the primary drying (Fonseca et al., 2015).   
Bacteria have to be properly formulated before freeze-drying, i.e. the growth 
medium in which they are cultivated must be exchanged to a protective aqueous 
solution in which the bacteria are up-concentrated. The formulation enables the 
formation of an amorphous glass matrix during freeze-drying. The amorphous 
glass phase is needed to protect the bacteria from the harsh conditions which they 
would otherwise experience during freeze-drying: high osmolality building up 
outside of the cells, cold stress, ice crystal formation damaging the membranes and 
the removal of water bound to lipids, cell wall and sensitive proteins leading to 
destabilization (Brennan et al., 1986; Meng et al., 2008; Fonseca et al., 2015). A 
properly chosen formulation both protects against the stresses of freeze-drying and 
assures the best stability during storage. Lactobacilli are commonly formulated in 
solutions of sugars and/or polymers, antioxidants may also be added but the best 
formulation is a rather species-specific matter (Schoug et al., 2010; Fonseca et al., 
2015). “Compatible solute” cryoprotectans can protect the cells from osmotic 
stress when accumulated by the cells, carbohydrate/polymer cryoprotectants and 
trehalose can increase the Tg’ which leads to a quicker inclusion of bacteria into 
the protective amorphous matrix (Meng et al., 2008) and prevents loss of the 
amorphous phase (Schoug, 2009). Other protectants such as fructo-
oligosaccharides and fructans can by interacting with membrane lipids protect the 
membrane from damage during freeze-drying, while sugars can protect sensitive 
proteins and lipids by interactions as well (Schwab et al., 2007; Fonseca et al., 
2015). 
In order to achieve good storage-stability, the water activity in the dried pow-
der must be low (Zayed & Roos, 2004), in other words, the samples must be well-
dried but a moisture content of 2-5% seems to be the optimum (Schoug, 2009). 
The cooling rate is also a significant factor on cell viability (Schoug, 2009). If the 
freeze-dried product will be stored at temperatures above Tc, the amorphous phase 
will collapse into a viscous phase or crystalize (Schoug, 2009). Nevertheless, it is 
important that the amorphous glass state is present during the primary step of 
freeze-drying, as it enables high survival of the freeze-drying process and a more 
complete drying which will affect subsequent storage-stability dramatically.  
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Tg’ has often been considered as the collapse threshold during primary drying, 
however, research provides evidence that collapsing actually takes place at the 
higher Tc (Fonseca et al., 2004a; b; Schoug et al., 2006). Tc is usually very close to 
Tg’ but it can differ substantially when bacteria are present in the solution (Fonse-
ca et al., 2004a). Tg’ is independent of initial concentration of the solute and it has 
been determined to be about -34 °C for Lactobacillus suspension in sucrose at cell 
functional units (CFU) per mL values up to 1010 (Schoug et al., 2006). Fonseca et 
al., (2004a) conclude that Tc is usually 10 °C above Tg’ for suspensions of lactic 
acid bacteria, which would mean that a Tc of -24 °C could be expected for the 
abovementioned bacterial solution. In (Fonseca et al., 2004a), the Tc of pure su-
crose solution was between -33 and -32 °C. In the same study, Tg’ and Tc (which 
were the same in this case) of a solution of 7.5 percentage by mass (wt %) sucrose 
with 1 wt % sodium ascorbate and 2.4 wt % ferment supernatant were -36 °C. 
Apparently, the additions of ascorbate and supernatant lowered the critical temper-
atures. Adding 8% (dry matter) of lactic acid bacteria to this solution raised Tc to  
-22 °C (although less detrimental collapsing at the microscopic scale began at -26 
°C) while Tg’ was -35 °C, which is indeed very close to the abovementioned Tg’ of 
the Lactobacillus solution in sucrose determined by Schoug (-34 °C).   
Tc (and Tg’ to a lesser extent) are also increased more by higher cell densities, 
and bigger, longer cells can raise Tc by several degrees more than very short cells 
(Fonseca et al., 2004b). Schoug (2009) mentions that secondary drying should be 
done below Tc too. Since the usual temperature for secondary drying is about 20 
°C (Fonseca et al., 2004b; a, 2015), it is important that the moisture level has de-
creased substantially during primary drying. 
As it was mentioned in the introduction, freeze-thaw survival (and hypotheti-
cally storage-stability) can be affected by preconditioning of the bacteria with 
various stresses and with different growth conditions. Such procedures alternate 
the molecular profile of the cells (Meng et al., 2008; Schoug et al., 2008; Liu et al., 
2014) and fermentation conditions influence cellular morphology (Palmfeldt & 
Hahn-Hägerdal, 2000; Koch et al., 2008). However, a potentially important fact is 
that the growth phase, in which the bacteria are during harvest, can be a precondi-
tioning factor as well (Meng et al., 2008). This was also observed to affect FT 
assay survival in the co-supervisors’ previous studies on L. reuteri DSM 17938 
(Garcia, Armando Hernández et al., unpublished). A problem arises because the 
pH and temperature will affect the duration of different growth phases. Therefore, 
if growth phase is not intended to be a variable of the analysis, it should be con-
trolled. 
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2.3 Accelerated storage 
Freeze-drying bacteria is a good way of extending their shelf-life and reducing the 
need for costly and unpractical storage conditions such as low temperature (Fonse-
ca et al., 2015). Nevertheless, the stability of freeze-dried bacterial powders is 
dependent on the temperature (Meng et al., 2008) and higher temperatures de-
crease the stability. This fact can, however, be used with advantage to model ex-
tended deterioration of powders within a shorter experimental timespan, by storing 
at a higher temperature – an accelerated storage assay (Franks, 1994). However, 
caution must be used in extrapolation of accelerated storage stability to standard 
storage stability: if the product undergoes a stepwise reaction towards deteriora-
tion or if phase transition occurs at the storage temperature, the extrapolation may 
be misleading and simple Arrhenius equation based extrapolations would not be 
appropriate (Franks, 1994). 
2.4 Growth Advantage in Stationary Phase (GASP) mutants 
Bacteria that grow in a batch cultivation, a type of cultivation where the amount of 
nutrients is predefined and limited and no new substrates are added during growth, 
go through four well recognized phases. The first phase after inoculation is the 
“lag phase” in which the growth rate is very low and the bacteria are adapting their 
gene expression to the new environment. After that comes the “exponential phase” 
also called “log phase” or “growth phase” in which bacteria grow exponentially at 
the maximum growth rate allowed by the conditions. Then comes the stationary 
phase, when the culture has suddenly run out of nutrients and waste products have 
accumulated. At this point, the bacteria stop dividing and their gene expression 
becomes adapted to starving conditions and stress tolerance (Zinser & Kolter, 
2004; Bačun-Družina et al., 2011). Eventually comes the death phase, in which the 
bacteria begin to die. This has been explained by different theories (Finkel, 2006): 
either that the bacteria have too little energy to support cellular maintenance func-
tions and become damaged by their own waste products or that the death phase is 
in fact a programmed collaboration strategy of the bacteria where only some mu-
tated bacteria do not obey the program and can reinitiate growth. This new growth 
is also called “long-term stationary phase” (Finkel, 2006), as it replaces the death 
phase. In either way, this is where Growth Advantage in Stationary Phase (GASP) 
mutants come in. The best survivors in the death phase are the mutants which pos-
sess some advantageous traits in the new situation where nutrients come from the 
remains of dead cells. In Escherichia coli for example, it is known (Zinser & 
Kolter, 2004; Finkel, 2006; Bačun-Družina et al., 2011) that GASP mutations en-
hance amino acid catabolism which helps in surviving on cell debris, enhance 
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tolerance to stressful pH and osmolality and prevents the cell from going into star-
vation mode. The GASP phenomenon has been studied extensively in E. coli, 
summarized by (Zinser & Kolter, 2004; Finkel, 2006; Bačun-Družina et al., 2011) 
and some studies have been done in other Gram negatives and Mycobacterium, 
summarized by (Zinser & Kolter, 2004), which also yielded GASPs. However, 
few studies have been done on this subject with Gram-positive bacteria (Bruno & 
Freitag, 2011; Sewell et al., 2011), the group to which Lactobacilli belong. 
A characteristic feature of GASP cultivations is that new mutant generations 
continue to appear in consecutive waves throughout the prolonged stationary 
phase, each generation having gained another mutation which makes it even more 
fit in the stationary phase environment. Thus, each new generation quickly takes 
over the culture, displacing the older generations (Figure 1). 
The behavior of GASP cultures is often depicted as well defined peaks in 
CFU/mL over time (Finkel, 2006; Bačun-Družina et al., 2011). However, the same 
sources explain that the total CFU/mL remains rather constant in the long-term 
stationary phase, with only tiny fluctuations representing the consecutive GASPs, 
while the well-defined peaks represent the CFU/mL counts of specific GASP vari-
ants/“generations”. It is explained that while the total CFU/mL is rather constant, 
there is a highly dynamic equilibrium between the dying old cells and the growing 
GASP cells of the newest generation (Zambrano & Kolter, 1996; Finkel, 2006) 
which has been experimentally proven (Zambrano et al., 1993; Finkel & Kolter, 
1999). According to a review (Finkel, 2006) by the author who also participated in 
many of the experiments in this subject, the first generation of E. coli GASPs rare-
ly appears earlier than after 8-10 days of cultivation. Furthermore, it has been 
demonstrated that when higher-generation GASPs are introduced as a highly-
diluted minority into stationary phase cultures of earlier GASP generations or non-
mutated young cell-lines, the higher generation GASPs take over the culture 
(Zambrano et al., 1993; Finkel & Kolter, 1999). Additionally, the viability of pro-
longed stationary phase GASP cultivations has been measured for up to 60 
months, still maintaining significant CFU/mL values (Finkel, 2006). 
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Figure 1. Representation of the growth of an Escherichia coli cultivation starting at inoculation and 
going far into the prolonged stationary phase. The black solid line represents the total CFU/mL count 
in the culture, it peaks at around 1×109 CFU/mL during early stationary phase. At around day 10 
from inoculation, the original “cell line” (now represented by the dashed black line) is displaced by 
the first generation of GASPs (G1), and so on. The total CFU/mL stays at a significant level even 
after 60 months. Based on (Finkel, 2006). 
The authors of a GASP study on Gram-positive bacteria (Sewell et al., 2011) claim 
that Enterococcus (a Gram positive) does exhibit the GASP phenomenon, howev-
er, that not all Gram positives display it, since it could not be observed in Staphy-
lococcus. These claims are based on observed fluctuations in viable count during 
stationary phase of Enterococcus but not Staphylococcus, when measuring viable 
counts for 85 hours (3.5 days) only. That fluctuations in viable count are a sign of 
GASP appearance, the authors refer to the paper by (Finkel, 2006), although this 
source explains that the total CFU/mL in fact remains quite constant during pro-
longed stationary phase. The cells sampled during the viable count peaks in (Sew-
ell et al., 2011) are shown to have enhanced pH and heat stability and hence are 
identified as GASPs. However, it is important to remember that even the extreme-
ly fast growing E. coli needs at least 8 days of cultivation before any GASPs can 
be found (Finkel, 2006) and also that the main GASP mutations confer enhanced 
amino acid scavenging, while general stress tolerance is ubiquitously exhibited by 
nonsporulating wild type cells shifting into starvation mode during the stationary 
phase (Zambrano & Kolter, 1996; Zinser & Kolter, 2004; Bačun-Družina et al., 
2011). Very unfortunately, the stress assays seem not to have been done on the 
Staphylococcus to see if it also gained increased tolerance despite no cell count 
fluctuations! One more GASP study on Gram positives could be found, a very 
elegant one, done in the same manner as the classical GASP studies. (Bruno & 
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Freitag, 2011) could demonstrate GASPs in 12-day old cultures of Listeria mono-
cytogenes which outcompeted non-GASP Listeria in fresh culture and the trait was 
stable in its heritability. This time, like in the classical GASP papers, there is no 
fluctuation of the total CFU/mL during the long-term stationary phase and the 
CFU/mL stayed at 10% of the maximum. 
2.5 Isothermal microcalorimetry 
An isothermal calorimeter is a device which can measure the heat production (heat 
flow) of various types of processes (e.g. chemical, biological and phase transi-
tions) with great sensitivity and display it as a heat flow curve in real-time. The 
reason it is called “isothermal” is because the device keeps the temperature of its 
samples at a constant value and measures how much heat that needs to be added or 
removed in order to do so. Isothermal microcaloritmetry (IMC) can be used in 
many fields of microbiology, for example in clinical settings to quickly identify 
infectious agents or the efficiency of antibiotics and in environmental and food 
science (Braissant et al., 2015). The metabolic processes in a sample are reflected 
by characteristics of the heat flow curve since metabolic processes are correlated 
with enthalpy production. IMC is beginning to win ground in the microbiological 
fields as it has many unique advantages over many classical methods (Braissant et 
al., 2015). It is especially praised for its sensitivity and flexibility when it comes to 
the physical characteristics of the samples, for example both liquid and opaque 
solid media can be used.   
2.6 Statistics 
This section will introduce the statistical concepts relevant to this study and also 
briefly mention some alternative methodologies which were considered. 
Identifying the influential factors for investigation and procedures for minimiz-
ing random and systematic errors are a crucial basis for quantitative research (Mil-
ler & Miller, 2010). However, when a study builds upon previous results, the se-
lection of factors of interest may not require screening experiments and many 
standard laboratory procedures for reducing error may already be established. 
A basic principle of scientific research is reproducibility. Statistical methods 
are used to quantify and visualize this reproducibility and so they need repeated 
experiments (Vaux et al., 2012). Some common terms used when referring to in-
dependently repeated experiments are “experimental repeats”, “sample sizes” 
(Vaux et al., 2012) and “biological replicates” (Fay, 2013). 
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Before applying a statistical method, one must go through the data and reject 
outliers. The most basal outliers for removal are the obvious ones (once effort has 
been put into finding them) which have some logical explanation in the lab notes, 
for example if the quality of a freeze-dried sample visibly diverged from the rest 
or some mistake was done. After this, there is an option to do a statistical outlier 
test, for example Grubb’s test (Miller & Miller, 2010). Grubb’s test requires a 
normal error distribution of the data. This can also be tested but a problem arises – 
the outliers may impact the normality of error distribution (Fay, 2013)! Therefore, 
a normality test could be performed before and after Grubb’s test and the removal 
of outliers. In general, one should be cautious in this procedure and having experi-
ence with the kind of data one is processing helps in the situation. 
Transformations of data are possible and sometimes needed before the statisti-
cal analysis. Many analyses require a normal (or at least not-too-far from normal) 
error distribution which means that a histogram of the distribution of the errors 
(“residuals”) should have similarity to the Gaussian curve. To achieve this, the 
data may have to be mathematically transformed. A popular transformation in 
biological sciences is the log-transformation because biological data often displays 
the “log-normal” distribution (Fay, 2013). However, transformed data may be hard 
to interpret in practical terms. Sometimes, it is feasible to back-transform the data 
after the statistical analysis. However, back-transforming from logarithms can only 
give the geometrical means and not the more commonly used arithmetical means 
(Montgomery, 1991; Fay, 2013). The geometrical means are similar to a median in 
the sense that they will show the most “typical” values of a data series; these 
means are not affected much by extreme values at the ends of the dataset (Fay, 
2013). 
A basic and very useful statistical concept is that of the confidence interval 
(CI). The CI tells within what interval the true value of a mean is likely to reside 
within a given probability (usually 95%). This information is easy to visualize so it 
helps to judge the results. The CI can easily be calculated with software, however 
it is dependent on the distribution of the data and so normally the assumption of 
normal distribution (Miller & Miller, 2010; Fay, 2013). Back-transforming CIs 
obtained in the logarithmic scale can only give the CIs of the geometric means 
(Montgomery, 1991). 
The most basic statistical test for significant differences is perhaps the Stu-
dent’s t-test. In a t-test, two means are tested against each other in the light of their 
variances and sample sizes. A so-called t-statistic is calculated, which is compared 
to tabulated critical t-values. The critical values depend on the number of degrees 
of freedom (d.f.): 
𝑑. 𝑓. = 𝑠𝑎𝑚𝑝𝑙𝑒 𝑠𝑖𝑧𝑒𝑚𝑒𝑎𝑛1 + 𝑠𝑎𝑚𝑝𝑙𝑒 𝑠𝑖𝑧𝑒𝑚𝑒𝑎𝑛2 − 2 (1.) 
20 
 
and the predefined significance threshold (p-value) (Miller & Miller, 2010). The p-
value is popularly set at 0.05 in biological research which means there is a 5% risk 
of accepting a random variation as a significant finding (a 5% risk of making a 
type I error). The most sensitive kind of t-test is the paired t-test, when applicable. 
It can be used when two different kinds of measurements or treatments have been 
done on the same material. This could for example be two treatments paired within 
batches and tested against each other. By comparing the differences between 
paired means, instead of just the overall means, the paired t-test separates the vari-
ance due to batches from the variance due to treatments which would otherwise be 
confounded (Miller & Miller, 2010). 
When more than two means or treatments are being compared, the t-test faces a 
problem. Namely, the “multiple comparisons problem”: the more tests that are 
being made with a 5% risk of having a type I error, the higher will this error inflate 
for the analysis as a whole. This total error is called the “family-wise error rate” 
(Fay, 2013). Fortunately, there are family-wise error rate corrections available 
such as the simple Bonferroni correction (Fay, 2013), in which the predefined p-
value (say 0.05) has to be divided by the total number of comparisons made in the 
statistical test. Only comparisons with a p-value below this new lower limit can be 
accepted as significant but still at the p=0.05 level. The Bonferroni correction has 
low power and is acceptable for small sample sizes and there are other correction 
methods for available for different situations. However, there are statistical meth-
ods other than the t-test which are specially designed for dealing with multiple 
means as well as multiple factors (multivariate methods). Perhaps the most com-
mon one is “ANOVA” with the Tukey test. These more advanced methods are by 
definition family-wise corrected. 
In the ANOVA method (Analysis of Variance), values called “F-statistics” are 
calculated from the ratio between variances attributed to each factor (or interaction 
of factors) and the variance which can only explained by random error (Montgom-
ery, 1991; Langsrud, 2003; Miller & Miller, 2010). These variances are expressed 
as “mean of squares” for the respective variance source. Then the ANOVA per-
forms so called “F-tests” by comparing the F-statistics with critical values, similar-
ly to what is done in the t-test. If the F-statistic is above the critical value belong-
ing to the pre-selected significance level (the chosen p-value, often 0.05) then a 
statistically significant finding is reported (with a maximum 5% risk for type I 
error). Using statistical software, an exact calculated p-value is reported and if it is 
below the p-value pre-selected by the researcher, it is a statistically significant 
finding. If the calculated p-values are much lower than the pre-selected ones, it 
indicates that the risk of a type I error may be even lower than what was judged as 
acceptable in the analysis. 
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The sums of squares (needed for the F-tests) can be calculated in different ways 
in ANOVA, called type I, type II and type III sums of squares. Type III is the most 
common standard as it is considered to cover all situations and is the usual default 
setting in statistical programs (Langsrud, 2003; Help - IBM SPSS Statistics). Some 
sources however, say that for an “unbalanced” design (when the sample sizes of 
the means are not equal) type II may be more appropriate (Langsrud, 2003). 
Factors under study, e.g. “treatment”, pressure or temperature, are called inde-
pendent variables while the measured outcome parameters, such as yield or stabil-
ity, are called dependent variables. Splitting the variance by defining more factors, 
such as batches, vials, bottles or dilution series can make the ANOVA more sensi-
tive, by making the random error term smaller (Miller & Miller, 2010; Krzywinski 
& Altman, 2014a). When defining “nuisance variables” (variables uninteresting to 
us but useful for increasing sensitivity) such as batch number into the analysis it is 
called “blocking” as data is divided into blocks. Furthermore, variance splitting 
can give quantification of how great each source of variation is, something that 
may be useful for scientific conclusions and planning of future experiments, for 
example by realizing that a certain experimental step is over- or under-replicated. 
However, blocking and in general defining more factors inevitably reduces the 
number of degrees of freedom (Krzywinski & Altman, 2014a). This has the oppo-
site effect on the sensitivity of the analysis, the less degrees of freedom there are, 
the higher becomes the critical value of the F-statistic to be reached in order to 
have a statistical significance. Therefore, blocking is only worth applying if the 
variance due to the blocking factor is indeed large (for example large variation 
between batches) so that the effect of variance separation is greater than the effect 
of loss of degrees of freedom (Krzywinski & Altman, 2014a). The efficiency of 
blocking in an ANOVA can be analyzed de facto. If it is uncertain whether using 
blocking will be beneficial when designing an experiment, it is recommended to 
do blocking – afterwards it can be assessed if it was beneficial and the potential 
losses due to the reduction of number of degrees of freedom are usually small 
(Montgomery, 1991). To calculate the benefit of blocking in some basic experi-
mental designs, a simple formula can be employed (Montgomery, 1991). Further-
more, just looking at the size of the ratio of mean square of the block factor to the 
mean square of the error provides rough information about the benefit of blocking 
(Montgomery, 1991). If it turns out that blocking was not beneficial, the future 
experiments should be completely randomized designs.  
There are two kinds of independent variables: fixed-effect factors and random-
effect factors. Fixed-effect factors are those which can be controlled by the exper-
imenter such as the treatment. Random-effect factors are those which cannot be 
controlled and vary randomly like the random error but can be identified and iso-
lated as a source of variance. Batches are often treated as a random factor, because 
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they can be seen as a random sample from endless possible batches (Montgomery, 
1991). The mathematical treatment in ANOVA differs slightly depending on 
which type a factor is (Montgomery, 1991; Miller & Miller, 2010).  
An ANOVA with one factor is called a “one-way ANOVA” and adding more 
factors will make it a “two-way ANOVA” and so on. At the heart of the ANOVA 
lies a mathematical model created for the experimental design, an ANOVA with 
one fixed and one random factor (a randomized block design) with no anticipated 
interaction between these factors will be represented by the model in equation 2 
(Montgomery, 1991):  
𝑦𝑖𝑗 = 𝜇 + 𝜏𝑖 + 𝛽𝑗 + 𝜖𝑖𝑗 (2.) 
where yij is the (ij:th) observation, µ is the overall mean of all the treatments, τi 
is the effect of treatment i, βj is the effect of block j and ϵij is the random error term 
accompanying each measurement. This is an additive model with no square terms 
because it does not consider interactions. 
There are different experimental designs available when doing an ANOVA. In 
the completely randomized design (CRD), no blocking is used even if batches are 
present in the experiment; the treatments are completely randomized over all 
batches (Montgomery, 1991). The block design comes in three main versions 
(Montgomery, 1991). The randomized complete block design (RCBD) has all 
treatment levels repeated in all blocks and these treatment levels are randomized 
only within blocks. The balanced randomized incomplete block design (BRIBD) 
does not contain all treatment levels in all blocks but each pair of treatment levels 
occurs together in a block the same number of times. Furthermore, each block 
contains the same number of treatment levels which are randomized within the 
block (randomized order of runs, machines used, etc.). Incomplete block designs 
may be necessary when it is physically impossible to fit all treatments into one 
block (the block is for example a batch) or as a means to save resources. Finally, 
there is the partially balanced randomized incomplete block design, in which the 
treatment level pairs do not need to occur together the same number of times. 
However, certain mathematical restrictions must be followed to keep the partial 
balance, which is out of the scope of this study. 
So, an ANOVA compares the means of the dependent variable to each other 
and looks for significant differences with respect to levels of factors. However, the 
ANOVA of a randomized incomplete block design (RIBD) computes and com-
pares something else than these simple mean values. It uses the “block adjusted 
means”, in SPSS called the “estimated marginal means” (EMMs), which are the 
treatment means adjusted by the effect of the blocking factor(s). In other words, 
EMMs are the treatment means predicted by the statistical “model” of the ANO-
VA, when the effects of the other factors have been compensated for. So, if block-
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ing has been used, the EMMs of the treatments are adjusted by the block means, 
according to which treatments were present in which blocks. This can be consid-
ered to be a more accurate representation of the treatment means than the unad-
justed means. For example, if batch x always gave the highest values, the means of 
treatments which contained batch x in their replications will be slightly lowered. 
SPSS also provides the 95% confidence interval (CI) for the EMM. 
The ANOVA only tells if there are any significant differences between the test-
ed levels of a factor, but not between which levels. Usually, an ANOVA is cou-
pled to a multiple comparison method for that purpose (Montgomery, 1991), often 
also called a post-hoc test (Fay, 2013), this latter term being ambiguously over-
used when it is in fact a special case of multiple comparisons. A popular multiple 
comparison method for making pairwise comparisons between all treatment means 
is Tukey’s Honest Significant Difference test (Tukey-HSD), commonly referred to 
as a post-hoc test (Fay, 2013). Tukey-HSD will compare all the means to each 
other for individual significant differences. It uses the mean square error term from 
the ANOVA analysis and so it is also influenced by variance splitting. If the de-
sign is unbalanced, a modified test, “Tukey-Kramer” must be used. SPSS does this 
automatically when provided with unequal sample sizes (IBM Does SPSS offer 
Tukey-Kramer post-hoc tests? - Sverige, 2016). 
Unfortunately, the Tukey-HSD can only be performed on the unadjusted means 
in SPSS, i.e. not the EMMs. This means that the effort of blocking is partly lost 
when it comes to Tukey-HSD, only the error mean square is reduced (due to split-
ting of variance into more factors in the ANOVA) but this always happens at a 
cost of losing degrees of freedom. Using the batch-adjusted EMMs uses the full 
potential of blocking. A way of using EMMs in Tukey-HSD manually and also get 
the resulting p-values is presented in section 3.5 of Material and methods. 
A very important aspect of any statistical significance test is “power”. As al-
ready mentioned there is a predefined risk of making a type I error (falsely reject-
ing a null hypothesis or in other words assuming a difference when there is none). 
Naturally, there is always also a risk of making the opposite kind of error: falsely 
retaining a null hypothesis or in other words missing a difference when there is 
one. This is the type II error and power is a measure of it according to equation 3 
(Montgomery, 1991): 
𝑃𝑜𝑤𝑒𝑟 = 1 − 𝑡𝑦𝑝𝑒 𝐼𝐼 𝑒𝑟𝑟𝑜𝑟 𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (3.) 
so power gives the probability of nailing a true difference. Power depends on the 
size of the difference between treatments to be observed relative to the standard 
deviation, i.e. the “effect size” and also the number of experimental repeats and 
the desired significance level (p-value) (Montgomery, 1991; Krzywinski & Alt-
man, 2014b). The greater the effect size and number of experimental repeats, the 
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higher power can be achieved. It is up to the experimenter how much power is 
desired but 80-95% seems to be the popular range (Lakens, 2013). When design-
ing an experiment, it is important to assess the power so that it is adequate for 
obtaining conclusive results. One has to decide about the minimal difference be-
tween treatments that will be scientifically interesting as a basis for defining the 
effect size and how many experimental repeats that can afforded. When it comes 
to experimental repeats, it is very important not to confuse these with “technical 
replicates” (Fay, 2013) or just “replicates” (Vaux et al., 2012). Experimental re-
peats are independent repetitions of an experiment while technical replicates are 
just repeated measurements within an experiment, such as replicated dilutions 
series or colony counts. Only experimental repeats can contribute to the sample 
size when using a statistical method to test the main hypothesis (Vaux et al., 2012; 
Fay, 2013).    
One should not rely on “observed power”/“post-hoc” power values, the power 
values given in the output of each SPSS ANOVA since they merely reflect the 
observed p-value. These observed power values show the power of the test with 
the assumption that the true difference between means is exactly the same as the 
measurements show. For power analysis to make sense, one should first decide 
what the difference between two means should be in minimum to still be interest-
ing scientifically, and only from that position can the true power of testing this 
predefined hypothesis be calculated. This difference would be a “scientifically 
interesting difference” and would be expressed in terms of the effect size. The 
definition of a “scientifically interesting difference”, together with the desired 
significance level and information (or informed guesses) about the variance (sum 
of squares) from previous experiments can show either the required total sample 
size needed to achieve a desired power level or the power level achieved with a 
given total sample size. There is software for assessing power, for example 
G*Power (Universität Düsseldorf: G*Power), SPSS Sample Power (IBM SPSS 
SamplePower, 2012) and many others.  
2.6.1 Statistics – the assumptions 
The first assumption of ANOVA is that the uncontrolled variation, the “random 
error” is truly random and not subject to some bias. This is achieved by using ran-
domization and blocking in the design of the experiments (Miller & Miller, 2010).  
Another assumption of ANOVA is homogeneity of variance: that the variance 
of the random error is not affected by treatment (Montgomery, 1991; Miller & 
Miller, 2010); in other words, the experimental repeats of each treatment will have 
an equal spread of their residuals. Some texts articulate this assumption as homo-
geneity of variance of the measured data values, since this often implies homoge-
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neity of variance in the residuals. This is, however, unprecise; if blocking has been 
used, the residuals may behave differently than the variance of measured data val-
ues. If it is assumed that the model provided by ANOVA is an additive one (no 
interactions) according to equation (2), the block effect term βj  can vary for each 
individual data value, depending on which batch it came from. Therefore, since the 
residuals are the observed values minus the values fitted by the model, the residu-
als may differ in homogeneity of variance from the raw data values. The values 
fitted by the model in the randomized block design with one fixed and one random 
factor are given by equation (4) (Montgomery, 1991): 
?̂?𝑖𝑗 = ?̅?𝑖. + ?̅?.𝑗 − ?̅?.  . (4.) 
where ?̂?𝑖𝑗 is the fitted value corresponding to the observation at treatment i and 
block j, ?̅?𝑖. is the mean of the observations at treatment i, ?̅?.𝑗 is the mean of the 
observations at block j and ?̅?.  . is the overall mean of the observations. 
Often, Levene’s test can be used to test for homogeneity of variance in a statis-
tically formal way. However, this test is only available for one-way ANOVA. In a 
multifactorial ANOVA, homogeneity of variance can instead be judged “by eye” 
from residual plots, in which residuals are grouped by the factor of interest, e. g. 
by treatment. This way, the spread (the variance) of each factor level can be visu-
alized and compared. There are some proposed rules of thumb for judging  homo-
geneity of variance from such residual plots (A Rule of Thumb for Unequal Vari-
ances | University of Virginia Library Research Data Services + Sciences). The 
optimistic rule is that the ratio of the widest variance over the narrowest variance 
should not exceed 3, but this is for large sample sizes. A safer ratio, especially 
with small sample sizes has been suggested to be 1.5. 
What to do if homogeneity of variance is not kept? If the homogeneity of vari-
ance assumption is unsatisfied, the ANOVA may be flawed. Solutions to this can 
be transformation of data which can improve the homogeneity (Montgomery, 
1991). Otherwise, non-parametric statistical methods may have to be applied 
(Montgomery, 1991; Miller & Miller, 2010).  
Another assumption of ANOVA is normality of distribution of the residuals 
(Montgomery, 1991), also called “normal error distribution”. However, ANOVA 
is not very sensitive to departures from this assumption (Montgomery, 1991; Mil-
ler & Miller, 2010).The Shapiro-Wilk test is a statistical test of normality and 
keeping with the standard of 0.05 significance threshold, a lower value than 0.05 
will imply that normality is violated with 95% confidence. Another way to assess 
the normality assumption is by examining the quantile-quantile probability plot 
(Q-Q plot) of the distribution of the residuals against the normal distribution (Wilk 
& Gnanadesikan, 1968). If the points on this plot align into a straight line, it indi-
cates a normal distribution of residuals. Deviations from such straight line are 
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classified into kurtosis and skewness. Kurtosis describes the clustering of the dis-
tribution of residuals against the central point while skewness describes the asym-
metry of the distribution (IBM Knowledge Center - Display Statistics). 
Many texts are unfortunately unprecise with the normality assumption and 
write it out as “normality of distribution” or “samples being drawn from a normal 
population” (Miller & Miller, 2010) which implies that the assumption applies to 
the distribution of measured data. It is true that normal distribution of data will 
usually mean normal distribution of error, so one can test the data for normality. 
However, more possibilities can open up when one is testing the residuals for 
normality instead. Most importantly and in contrast to the data values, all the re-
siduals from the different treatments can be tested for normality together as one 
group, instead of testing the normality of each treatment group separately (Mont-
gomery, 1991). This helps to get a sensible and reliable normality test when the 
sample sizes are small (few measured values per treatment). If the normality as-
sumption is grossly unsatisfied, the options are either finding a transformation for 
the data or using so called non-parametric and robust methods (Miller & Miller, 
2010). 
A final assumption when having a multifactorial design and not intending to 
test for interactions between factors (and to be morally correct - not expecting any 
interactions) is the additivity of the mathematical model behind the ANOVA 
(Montgomery, 1991). This means that a linear model with no square interaction 
terms adequately explains the observations. However, in a two-factorial block 
design where one factor is a random-effect factor, this assumption is unnecessary 
(Montgomery, 1991). Otherwise, plotting the residuals against the dependent vari-
able values predicted by the model and looking for non-random patterns in the 
scatter is a way to detect unexpected interactions between the factors when using 
an additive model (Montgomery, 1991).  
27 
 
3.1 Overview of the correlation experiment 
A schematic overview of the correlation experiment designed to address the first 
objective of the thesis is presented in Figure 2 below. 
 
Figure 2. An overview of the correlation experiment, in which the relationship between survival of 
the freeze-thaw assay and survival of the accelerated storage assay was investigated, depending on 
cultivation settings (treatments A, B and C). 
3 Material and methods 
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3.1.1 Fermentation and formulation 
Lactobacillus reuteri DSM 17938 was cultivated in three Jenny bioreactors from 
Belach Bioteknik AB at three different settings of pH and temperature. These three 
“treatments” were “A” = 37 °C, pH 4.5; “B” = 32 °C, pH 4.5; and “C” = 32, °C 
pH 6.5. The three treatments were chosen on the basis of the co-supervisors’ earli-
er studies of FT-assay stability as being the best, the midst and the worst precondi-
tioning, respectively (Garcia, Armando Hernández et al., unpublished).   
Seven batches were run in total, allowing each treatment to be replicated four 
times, see Table 1. In batches 1-3, three bioreactors were employed one for each 
treatment (A-C). In batches 4 to 7, only two bioreactors could be employed at a 
time with treatments A-C evenly distributed between batches. Batch 7 was a repe-
tition of the same treatments as batch 5, because batch 5 was a collapsed batch and 
lost viability quickly in accelerated storage (more on this in section 4.3 of Results). 
These two batches were never used in the statistical analysis for the same 
timepoint of storage-stability measurement, leaving the sample size at four, as seen 
in Table 1. 
Table 1. Example of the design of experiment for storage-stability measurement after 7 days of ac-
celerated storage. Batch 3 was never freeze-dried and so did not take part of the study, batch 7 was 
not investigated at the 7th-day timepoint. 
Batch number Available treatment replicate 
1 A B C 
2 A B C 
4 A - C 
5 A B - 
6 - B C 
7 - - - 
All liquid cultivations, including the main fermentations as well as the prepara-
tions of inoculum were done in De Man, Rogosa and Sharpe (MRS) broth medium 
for Lactobacillus from Merck (Darmstadt, Germany). For inoculum, cell bank was 
thawed on ice for 20-40 minutes, a single cell bank could be re-frozen once and 
used for the next batch (small test experiment showed that cells from a doubly 
frozen cell bank grew equally well in inoculated bottles). A 10-mL bottle of MRS-
medium was inoculated with 10 µL of the cell bank and put into 37 °C for six 
hours. After six hours, high turbidity had developed and the contents were homog-
enized before 3 x 500 µL was transferred to three 100 mL Duran® bottles filled 
with 100 mL MRS medium. These bottles were cultured at 37 °C overnight for 
about 15-17 hours. Large amounts of (presumably) CO2 bubbled out of the fin-
ished cultures when these were homogenized. The starter culture was drawn into 
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three inoculation syringes and the syringes were knocked on during drawing of the 
inoculate as to minimize the volume occupied with CO2. The optical density at 
600 nm (OD600) of the finished 100 mL starter cultures was also checked and it 
was always around 8. All of the work was done with use of thorough aseptic tech-
nique and with the aid of a sterile bench.   
The reactors were filled with 1 L of MRS medium each, autoclaved and let 
cool to room temperature. Inoculation of the reactors was done by adding 48 mL 
inoculate (40 mL in batch 1) using sterile needled syringes through ethanol-
flooded rubber membranes at the reactors. The mixing of the reactors was set at 
100 rpm and no aeration was applied. This together with pH and temperature (spe-
cific for each treatment) was controlled by a computer connected to the bioreactor 
setup, including pH and temperature electrodes in the reactors. The pH was adjust-
ed by automatic pumping of NaOH solution 20 % w/v (it is possible but untracea-
ble that for some batches, another solution was used which was made by diluting 
200 g of NaOH in 1 L of water). Acid (H3PO4, 3 M) was added manually with a 
syringe, very slowly, to adjust pH in rare cases when this was needed.  
Since different cultivation conditions lead to different durations of growth 
phases (for example treatment A with its high, growth promoting temperature 
would reach the stationary phase quickest), the harvesting times had to be adjusted 
accordingly. Based on the co-supervisor’s previous results (Garcia, Armando Her-
nández et al., unpublished), it was decided to divide the observed stationary phase 
(between the end of exponential growth phase and start of death phase) into three 
equal intervals: early, middle and late stationary phase. The early stationary phase 
starts when the growth, measured by OD, planes out. It was desirable to harvest all 
biomasses at an equivalent phase, to minimize the effect of this additional factor 
which in this case was a factor beyond the experimental scope. It was decided that 
it would be most practical to harvest the biomasses individually as soon as each 
reaches its own middle stationary phase. According to the previous unpublished 
studies, each of the chosen treatments would not only reach early stationary phase 
at different times but would also take a somewhat different time to reach middle 
stationary phase from that point. OD600 was measured (in triplicates) both to spot 
the early stationary phase of treatment A as a reference for when to start the har-
vesting, and to check if the cultures are growing well. Cultivation A usually 
reached early stationary phase after 8.5 hours, the other cultures were, based on 
the earlier unpublished studies, assumed to reach early stationary phase 4 hours 
later (B) and 2 hours later (C). In most batches, it took roughly the same time for 
cultivation A to reach early stationary phase and for a few cases, it had to be as-
sumed that the stationary phase was reached just after the end of the measurements 
as it got too late to continue the readings. Harvesting was aimed at the middle 
stationary phase which was assumed (based on the previous unpublished results) 
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to be reached after 14, 13 and 13 hours from the start of the early stationary phase 
for treatments A, B and C, respectively. However, in practice the harvests were 
delayed by on average an additional hour, because of practical issues. Table 2 
summarizes the time-schedule of the cultivations. 
Table 2. The approximate time-schedule of growth phases and harvesting of the three cultivation 
types (A-C). Based on the co-supervisors’ previous results (Garcia, Armando Hernández et al., 
unpublished). ESP = Early Stationary Phase, MSP = Middle Stationary Phase. The rightmost col-
umn shows when the harvests were done in practice 
Treatment Approximate time to 
reach ESP (h) 
Approximate time to 
reach MSP (h) 
Approximate time to 
harvest (h) 
A (37 °C, pH 4,5) 8.5 22.5 23.5 
B (32 °C, pH 4,5) 12.5 25.5 26.5 
C (32 °C, pH 6,5) 10.5 23.5 24.5 
Harvesting was done by pumping out the ferment from the reactor through a rub-
ber tube and into a closed bottle, using one of the reactors own feed-pumps. The 
outlet of the tube was kept at the bottom of the bottle so that to avoid unnecessary 
oxygen shocking (although this detail was employed starting at batch 4, after some 
discussions of potential effects of oxygen). Pumping for sample collecting went on 
for about an hour to obtain 500 mL, and then the sample was gently poured down 
into a pre-weighted centrifuge flask. The ferment was centrifuged at 4200 rpm, 24 
°C for 30 minutes. The supernatant was discarded and the bottle was again 
weighted to determine the weight of the bacterial pellet. The bacterial pellet was 
resuspended with sterilized and deionized water up to a total weight of 50 g, then, 
50 g of sucrose solution (30% w/v) was added. To resuspend the pellet, vigorous 
flushing with a large electrical pipette (about 25 mL suction volume) was done for 
10 minutes for all cases to be fair with the oxygen shock, no matter how fast a 
particular pellet dissolved. This resulted in a 15% w/v sucrose formulation and a 
5-fold increase in the concentration of bacteria relative to the original ferment. All 
the numbers and graphs in this paper are based on this up-concentration as the 
standard, no compensatory re-calculations were done. The formulated and resus-
pended biomass was, while kept well-mixed, distributed with an electrical pipette 
into small freeze-drying vials (20mm neck 45x24/1mm), 2 mL into each vessel 
and usually 23 vessels per treatment in each batch. The vessels were color marked 
by treatment and arranged randomly in a tray, corks were put in place and the ves-
sels were put into a -50 °C freezer for at least 2 hours to be well frozen before 
freeze-drying. The remaining formulated biomass was used on viable counts to 
give a reference starting CFU/mL value for subsequent calculations of survival.  
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3.1.2 Freeze-drying 
Batch 1 and batch 2 were freeze-dried in a highly-automated freeze-drier (LyoStar 
II™, FTS Kinetics™, Stone Ridge, NY, USA). Batch 3 never got through with 
freeze-drying since the machine broke, so this batch was not included in the corre-
lation experiment. All the subsequent batches were run in a simpler freeze drier, 
(FreeZone® 12, Labconco, Kansas City, Missouri, USA).  
First, the freeze-drier was cooled down to a shelf temperature of -40 °C. The 
pre-frozen samples were transferred to the freeze drier as quickly as possible 
(within several minutes). Three randomly chosen samples had previously been 
given thermocouples immersed in the biomass in order to measure the actual 
freeze-drying temperature at different locations of the shelf. As soon as the sam-
ples were inside the freeze-drier, the vacuum pump was turned on. The tempera-
ture of the “probed” samples was watched. There was always a rise in the tempera-
ture of the probes to above -40 °C because of warming up during the transport and 
the opening of the machine. The pressure had to drop adequately before the shelf 
temperature could be increased, i.e. starting the actual freeze-drying process. It 
was aimed for to lower the pressure to about 5 Pa before rising the shelf tempera-
ture to -20 °C. This shelf temperature was kept for a few days before it was in-
creased by subsequent 10 °C steps every second hour up to +10 °C for batches  
1-5; the final temperature was however increased to +20 °C (in batch 6 and 7) as 
an attempt to improve the dryness of samples. The final temperature was kept for a 
final couple of freeze-drying hours.  
However, the 5 Pa goal was hard to reach and various starting pressures had to 
be accepted because of lack of time. Batch 4 presumably reached 6 Pa but the 
shelf temperature was decreased to -24 °C because one of the probes measured as 
high as -30 °C too early in the primary drying. The temperature was adjusted back 
to -20 °C the following day. Batch 5 reached 16 Pa and batch 6 reached 11 Pa but 
the shelf temperature was decreased to -24 °C because the pressure jumped to 16 
Pa when increasing the shelf temperature. It is possible that the temperature was 
left at -24 °C until the stepping up (there are no notes of increasing it to -20 °C). 
Batch 7 reached 11 Pa but the shelf temperature was only increased to -30 °C be-
cause one of the probes measured as high as -28 °C. The shelf temperature was 
increased to -20 °C the next day. Note that the pressure gauge was not very precise 
and would show only certain step-wise values. 
After the final stepping up of the shelf temperature, the corks on the vials were 
closed by the freeze-drier, still at low pressure. 
During the making of batch 2, empty freeze-drying vials were pre-weighted 
and then weighted again with freeze-dried biomass in order to investigate the vari-
ability and how much saline (0.9% w/v) was needed for resuspension of bacterial 
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cakes back into 2 mL liquid (or rather as an approximation, 2 g liquid). The varia-
bility was small, with a difference between the heaviest and the lightest sample 
being only 0.71%. The cakes weighted on average 0.3000 g and were therefore 
from there on resuspended in 1.7 mL saline for viable counts (except for batch 1 
where 1.8 mL had been used at all times). This over-dilution of batch 1 was com-
pensated for in the calculations of CFU/mL in the subsequent viable counts. Im-
portantly, the reference formulated biomass before freeze-drying was omitted from 
this correction because it did not need any resuspension. 
3.1.3 Accelerated storage assay 
As soon as the closed freeze-drying vials were out of the freeze-drier, they were 
sealed with extra metal caps and stored at 37 °C for up to 29 days (accelerated 
storage assay). One aliquot was used directly for taking an initial survival viable 
count (VC) and the rest after 3±1 days, 7 days, 14 days, 22 days and 29 days. The 
discrepancy at around the third day of accelerated storage (±1 day) was due to 
practical issues. It was decided to pool these measurements into one “3 days” 
measurement point for the statistical analysis. 
Before doing any VC, the look of the bacterial cakes was noted as well as some 
other characteristics. Because of large possible variability in the samples, a routine 
for selecting the most average-looking vials of each type was introduced starting 
from the 3 day VC of batch 4. At the same point, a quality scale was set-up for 
annotating how much each chosen sample had shrinked both in absolute terms 
(compared to how much possible shrinkage had been observed in batch 1) and 
relatively to the other samples of the same treatment (A-C) in the same batch. The 
scale would give one, two or three minuses in the absolute shrinkage assessment 
and a plus, zero or minus in the relative part. For example a(---)r(+) would mean 
that in absolute terms, the sample has shrinked very much but relative to the others 
of the same type, it is relatively big. The quality scale together with annotation of 
color and texture was very helpful in identifying some outliers and to see the con-
nection between looks and survival rate.  
3.1.4 Freeze-thaw assay 
The three cultivation condition treatments chosen for this study were based on the 
co-supervisors’ previous results of a FT-assay (with a different protocol than the 
FT-assay used for this paper) as the best, the midst and the worst survivor and had 
the following survival ratios: best - 32 °C, pH 4.5 -> 39%, midst - 37 °C, pH 4.5 -
> 9.49%, worst - 32 °C, pH 6.5 -> 2.5% (Garcia, Armando Hernández et al., un-
published).  
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The protocol applied for the FT assay was adopted from previous research in 
the BioGaia project (persons. comm, Malin Sundelius, BioGaia AB), with some 
minor modifications. The freeze-dried bacterial cakes for the FT-assay were kept 
in the freezer at -50 °C overnight after the freeze-drying. The following day, sam-
ples of 0.1 g of the freeze-dried cakes were dissolved in 43 mL saline (0.9 % w/v), 
technically replicated in duplicates by using two individual freeze-drying vials 
from each treatment (A-C). The solutions were left to stand for 30 minutes – 60 
minutes. A viable count was done on the solutions to obtain starting CFU/mL val-
ues for reference. Thereafter, 300 µL of each solution was transferred to 1.5 mL 
Eppendorf tubes. These Eppendorf tubes were frozen for at least 50 minutes and 
then thawed in a heating block at 37 °C for 10 minutes. This was repeated three 
more times until four freeze-thaw cycles had been done. One of these four freezes 
lasted overnight, which one it was could differ between batches. In the end, the 
freeze-thawed samples were plated, about 48 hours after the end of freeze-drying.   
3.2 GASP experiment 
To address the second objective of the thesis, two attempts were made to capture 
GASPs using IMC. In the first attempt, two sets of small ampoule cultivations 
were done: one with standard MRS medium (Merck) and the other with 1:2 diluted 
MRS medium (“half-MRS”). The idea with the half-MRS was that with less nutri-
ent supply, the Lactobacilli should accumulate less acidity. This was of interest 
because it was suspected that a too acidic environment could inhibit the arise of 
GASP cultures.  
The experiment was performed in a pair of isothermal microcalorimeters 
“TAM Air 8-channel” (TA instruments, New Castle DE, USA). Small, sterilized 
microcalomietry ampoules were filled with 18 mL of MRS-broth medium and 
half-MRS-broth medium, 8 ampoules of each. Sixteen more ampoules were filled 
with 18 mL of water as the baseline references for calorimetry; each reference 
ampoule shared a two-slot “channel” with a fermentation ampoule. The fermenta-
tion ampoules were inoculated with 10 µL of thawed cell-bank. All of the am-
poules were closed with sterilized rubber/metal caps, small hooks were screwed 
halfway through these caps as a means for carefully sending down the ampoules 
into the calorimeters. To avoid CO2 buildup, tiny sterile syringe-needles were 
struck through these caps. The needles were not driven down as far as to touch the 
liquid in order to avoid any capillary actions. The handling of the ampoules and 
the caps was done through vinyl gloves to avoid contamination with grease, which 
could interfere with the readings. The calorimeters were heated up to 37 °C, the 
baseline was established by the co-supervisor and then all the samples and refer-
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ences were carefully submersed into the slots. The cultures were continuously 
cultured at 37 °C and their heat fluxes were measured for 17 days. At the end, two 
ampoules of the full-MRS-broth medium type were subjected to VC with single 
dilution series. The plaque buildup at the bottom of the ampoules had been thor-
oughly vortexed up into solution. The rest of the ampoules were transferred to a 37 
°C incubator as the calorimeter was unavailable for a while. Five days later, two 
more ampoules of the whole-MRS-broth and one ampoule of the half-MRS-broth 
were investigated with VCs. Simultaneously, their pH were measured with a pH-
electrode. 
Due to unsatisfactory results of what was described above, a second attempt of 
the GASP experiment was done. The second attempt began by composing and 
testing an array of buffered versions of the half-MRS and whole-MRS media with 
the aim to prevent the pH from getting too acidic during cultivation by buffering 
action. The test-cultivations were done to assess the growth of L. reuteri and sta-
bility of pH in the different media. The cultivations were done in a RTS-1C Per-
sonal Bioreactor (BioSas, Riga, Latvia) which uses specialized Falcon tubes as the 
reaction vessels. The buffer of choice was MOPS (3-(N-
morpholino)propanesulfonic acid), initially at the concentration 5.6 g/L, based on 
previous experiments on Lactobacillus for BioGaia (persons. comm, Stefan Roos, 
BioGaia AB). To make this medium, MOPS in powder form was weighted up and 
dissolved in 100 mL MRS-broth. From the resulting MOPS-MRS solution, 30 mL 
was sterile-filtrated into a sterile falcon tube. The tube was inoculated with L. reu-
teri from fresh colonies belonging to the other experiments, straight from a Petri-
dish cultivated at 37 °C. The Falcon tube was inserted into the Personal Bioreactor 
and fermentation was done at 37 °C without continuous spin agitation. The cap of 
the Falcon tube had a membrane for CO2 release. The OD (850 nm) was automati-
cally measured every tenth minute (preceded by a quick spin-homogenization) and 
plotted on a computer connected to the bioreactor. The next day, when the culture 
was in death phase, its pH was measured with a pH electrode together with a tem-
perature electrode for temperature compensation. pH measurement was also done 
to the fresh MRS-broth and fresh MOPS-MRS-broth. The whole procedure of 
cultivation in the Personal Bioreactor and measurement of pH was also repeated 
with half-MRS-broth medium containing 5.6 g/L MOPS buffer and finally, with 
half-MRS broth medium containing 11.2 g/L MOPS buffer. In the last case, the 
pH was measured after three days of cultivation.   
At the second attempt of microcalorimetric GASP hunting, things were done in 
the same way as in the first attempt, except for a mistake due to a misunderstand-
ing: the baseline was not established before inserting the samples. This eventually 
led to such a solution that the experiment (the collection of heat flow data) was 
started when samples reached stationary phase. Furthermore, in this experiment 
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the samples were: eight ampoules of half-MRS broth with 11.2 g/L (“twice-”) 
MOPS buffer freshly inoculated with L. reuteri, four ampoules with the old death 
phase cultures in whole-MRS-broth (taken back from the 37 °C incubator) and 
four ampoules inoculated with E. coli strain TG1 in LB broth medium. The latter 
cultures were implemented as a means to verify if the GASP phases of E. coli 
cultures (Zinser & Kolter, 2004; Finkel, 2006; Bačun-Družina et al., 2011) are 
visible at all within the heat fluxes (assuming that the GASP phenomenon would 
in fact take place). The E. coli were not freshly from a cell bank but from a previ-
ous cultivation. After eight days of cultivation, two ampoules of the half-MRS 
twice-MOPS cultures were taken out for VC and pH measurement. The other cul-
tivations were kept and measured in the microcalorimeter for 19 more days. 
3.3 Saline experiment 
At some point in the middle of the experiments it was discovered that for some 
time, perhaps two weeks or so, the saline solution used for rehydrating freeze-
dried samples had accidently been made at the concentration 0.09% w/v instead of 
the standard 0.9% w/v. To judge the impact of this mistake on the results, a small 
experiment was performed to see the effect of saline concentration on VC.  
The biomass for this experiment was a surplus vial: after freeze-drying of batch 
7 was complete, some samples were put into the freezer at -50 °C for freeze-thaw 
assay and there were enough of them to also use for the saline test. The next day, 
one such vial was sacrificed; two dilution series were done with 0.09 % w/v saline 
and two dilution series with 0.9% w/v saline. The dilution series were plated on 
Petri-dishes in triplicates.  
3.4 Viable counts 
The colony cultivations for VC were done in Petri-dishes with MRS-agar for Lac-
tobacillus from Merck (Darmstadt, Germany). The biomass was diluted in a ten-
fold dilution series (steps of 1:10 with a transfer volume of 100 µL) in 0.9% w/v 
saline (0.09% in some cases, see “Saline test” in Results section 6). 10 µL of each 
dilution of interest was dropped down on the agar and let run in one direction by 
tilting the plate, up to four dilutions per plate (Jett et al., 1997). The dilution series 
was always technically duplicated. The formulated biomass before freeze-drying 
was drawn twice and used for two dilution series, the accelerated storage assay 
VC-measurements were done by using two freeze-drying vials of each treatment 
and likewise, all VCs in the FT-assay and most in the GASP experiment were 
based on technical duplicates of dilution series based on duplicates of vi-
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als/ampoules. Each dilution series was in turn duplicated on two Petri-dishes, in 
rare cases on three. In each Petri-dish, the number of dilutions within a countable 
range varied and each countable dilution was included in the chain of duplications. 
This bottom step of duplication constitutes the lowest level “technical replicates” 
which were averaged to give on mean value. Values of the biological replicates 
(repeated experiments), which means the individual batches, were kept un-
averaged for the statistical analysis, in accordance with statistical literature (Vaux 
et al., 2012; Fay, 2013; Krzywinski & Altman, 2014a). 
The inoculated Petri-dishes were incubated anaerobically in tightly closed spe-
cialized jars together with applied Anaerocult® reagent (Merck). The jars were 
kept at 37 °C for about two days until colonies had developed. The maximum 
number of colonies for a dilution drip to be considered countable (and reliable) 
was around 180. In a few rare cases, especially when data was sparse, values of up 
to 239 colonies were accepted. Usually however, the values were in a moderate 
range (from a few to about a hundred colonies). If some technical replicates (at the 
“drip” level) of a particular high-end dilution included a count of zero colonies, 
then this dilution was only included into the total average if there was a higher 
dilution available which had only zeroes. This was to guard against bias from ac-
cidental contamination of samples with the bacteria which would produce a high 
background noise of colony growth. Because if some samples have the value zero, 
it makes the non-zero ones more suspect, while the effect of this background noise 
is not equally drastic on higher colony counts of lower dilutions.  
The CFU/mL was calculated as following: 
𝐶𝐹𝑈
𝑚𝐿
= 100 × (𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑛𝑜.  𝑜𝑓 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠) × 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 (5.) 
The factor 100 in equation (5) is to compensate for the fact that drops of only 10 
µL are used for plating while the CFU is given per mL. The “survival fraction” 
was calculated by dividing a CFU/mL of interest by the average CFU/mL of the 
formulated biomass before freeze-drying for a particular treatment (Eq. (6)). 
𝑠𝑢𝑟𝑣𝑖𝑣𝑎𝑙 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 = 
=  
𝐶𝐹𝑈
𝑚𝐿  𝑜𝑓 𝑖𝑛𝑡𝑒𝑟𝑒𝑠𝑡, 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑋
𝐶𝐹𝑈
𝑚𝐿 𝑓𝑜𝑟𝑚𝑢𝑙𝑎𝑡𝑒𝑑 𝑏𝑖𝑜𝑚𝑎𝑠𝑠 𝑏𝑒𝑓𝑜𝑟𝑒 𝑓𝑟𝑒𝑒𝑧𝑒 𝑑𝑟𝑦, 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑋
 
 
(6.) 
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3.5 Statistics - correlation experiment 
The stability data was thoroughly examined to remove any outliers or unreliable 
data according to what was described in sections “Accelerated storage assay” and 
“Viable counts” above. Since the consistency in the remaining technical replicates 
seemed reasonable and the time was limited, no formal statistical test for outliers 
was applied.  
The design of experiment (de facto) was an unbalanced randomized incomplete 
block design for a two-way ANOVA in SPSS followed by post-hoc Tukey-HSD 
tests. The fermentation treatment was selected as a fixed factor with three levels 
(treatments A, B and C) and batch number was selected as a random factor. One 
set of data was prepared for ANOVA by averaging the technical replicates into 
means for each batch/treatment combination, and one dataset was log10-
transformed at the level of technical replicates which were then averaged into 
batch/treatment combination means. The log10-transformation was used with the 
aim to improve compliance of the data to the assumptions of the statistical tests 
used, as well as to increase their power. 
Completely separate ANOVAs were done for each timepoint of accelerated 
storage stability measurement and for the FT-assay, as well as for the non-
transformed and logarithmized versions of these analyses. Table 1 in section 3.1.1 
“Fermentation and formulation” above shows an example of the experimental 
design for accelerated storage assay at 7 days of storage (not all timepoints had the 
same number of available batches, especially batch 1 was no longer viable after 14 
days).  The number of biological replicates at each timepoint of storage-stability 
measurement can be found in Tables 6 and 7 in section 4.3 “Survival in accelerat-
ed storage assay” and for the FT-assay in Table 9 in section 4.4. The reduction of 
batch size from three to two treatments after batch 3 was done because firstly, in 
batch 4, one of the cultivations failed due to a malfunctioning pH-electrode and 
there was no replacement for this electrode available within time for further culti-
vations. Secondly, because operating all three bioreactors at the harvesting day led 
to very stressful working load for a single person. 
The smallest observable value in viable counts was 102 CFU/mL (one colony 
observed per mL when using 10 µL drops), so if no colonies were observed, the 
count was set to 10 CFU/mL. However, since survival ratio values were needed 
for the statistical analysis and correlation plots, the 10 CFU/mL minimal values 
were divided by the highest observed initial CFU/mL in the study (7.88×109). This 
was needed for the logarithmized part of analysis because a zero on the logarith-
mic scale would mean 100% survival. For plots of the CFU/mL over time in this 
paper though, the value 10 CFU/mL was used as the minimum. 
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Each ANOVA was accompanied by an analysis of standardized residuals in 
SPSS to check if its assumptions were satisfied. Normal Q-Q plots and Shapiro-
Wilk tests were done to assess the normality of error distribution and additionally, 
kurtosis and skewness values were evaluated. These tests were done for each sepa-
rate ANOVA using pooled standardized residuals from all treatment groups (A-C). 
The results of these tests were compared between the non-transformed and log10-
transformed datasets at each timepoint of accelerated storage assay measurement 
and for the FT assay survival. The homogeneity of variance assumption was as-
sessed by plotting standardized residuals versus treatments (A-C) and calculating 
ratios between the greatest and smallest within-treatment variance of residuals, in 
order to compare the result with the rule of thumb ratio of at most 1.5 for small 
sample sizes. The results were compared between the non-transformed and log10-
transformed datasets. 
After the ANOVA, Tukey-HSD tests were run to compare the individual 
means. To be able to use the EMMs instead of the unadjusted means, Tukey-HSD 
tests were done manually in Excel (since SPSS does not perform Tukey-HSD on 
EMMs) according to equation 7 (Montgomery, 1991): 
𝑇𝛼 = 𝑞𝛼(𝑎, 𝑓) × √
𝑀𝑆𝐸
𝑛
 
(7.) 
where Tα is the critical value for a pairwise difference at significance level α, 
qα(a,f) is the statistic for the studentized range distribution at the significance level 
α, number of compared groups a and f degrees of freedom of the error (provided 
by SPSS ANOVA), MSE is the mean square error (provided by SPSS ANOVA) 
and n is the sample size. Solving for qα(a,f) and substituting Tα with the observed 
difference between means gives equation (8): 
𝑞 =
𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝑚𝑒𝑎𝑛𝑠
√𝑀𝑆𝐸
𝑛
 
(8.) 
These calculated q values could be compared to tabulated critical values in order 
to tell which comparisons were significant. However, to do this conveniently and 
to also get the actual p-values out of the Tukey tests (rather than a yes/no answer), 
a Matlab script was employed, the “cdfTukey” (Cumulative distribution function 
of the studentized range (for Tukey’s HSD test) - File Exchange - MATLAB Cen-
tral). When provided with q, a and f, cdfTukey gives the “cumulative distribution 
function of the studentized range distribution used in Tukey's HSD test” (cdf). 
Then 1 - cdf = p-value of Tukey HSD. 
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3.6 Microscopy 
Starting at batch no. 4, microscopic studies were implemented as another way of 
correlating measurable outcomes with storage-stability. For obtaining casual im-
ages of cell size and morphology, samples were taken just before starting the har-
vest or just after finishing the harvest. The samples were kept at room temperature 
and were observed under phase-contrast microscopes within one hour after sam-
pling. The exception were samples from treatment B, these had to be viewed after 
3 hours due to practical reasons in the time schedule of laboratory tasks. For the 
Gram-stain, samples were taken together with the abovementioned samples and 
were stained near the time when the abovementioned samples were viewed.  
The Gram staining protocol was adopted from (Smith & Hussey, 2005): 1 mi-
nute of primary stain -> 2 seconds of washing -> 1 minute of mordant -> 2 seconds 
of washing -> 15 seconds of decolorizing -> 45 seconds of counterstain -> final 
wash.  
The lens scales (ocular micrometers) seen in the microscopy images in the Re-
sults section do not represent µm directly but have to be compared to a µm refer-
ence (objective micrometer) for each of the two microscopes used (home lab and 
course lab microscopes), individually and recalculated into micrometers. This was 
done with the help of reference photos for each microscope (Figure 27 in Appen-
dix). 
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4.1 Growth during cultivation 
Batch-wise results from measurement of OD600 during the growth of L. reuteri in 
bioreactors at the three treatments (A-C), up to the point when the fastest culture 
(A) had reached stationary phase are plotted as the natural logarithm of OD600 over 
time in Figures 3-5. The entrance into stationary phase was recognized by a halt in 
the increase of ln(OD600) over time, which was generally reached for all batches of 
treatment A. It can be observed that there is least spread in cultivation with treat-
ment C even when only comparing among those batches that actually contained 
treatment C (batches 1-4 and 6), this possibly indicates a more robust growth pro-
cess. Furthermore, the ln(OD600) curves indicate that exponential growth, seen as a 
straight line when looking at ln(OD) graphs, ceased after 2-3 hours (treatment A) 
or 4-5 hours (treatments B and C) and became more of a linear growth, seen as a 
gradual flatting out of the curve. 
4 Results – correlation experiment 
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Figure 3. The growth curves during fermentation using treatment A (37 °C, pH 4.5), represented as 
the natural logarithm of the optical density (OD) at 600 nm. 
 
Figure 4. The growth curves during fermentation using treatment B (32 °C, pH 4.5), represented as 
the natural logarithm of the optical density (OD) at 600 nm. 
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Figure 5. The growth curves during fermentation using treatment C (32 °C, pH 6.5), represented as 
the natural logarithm of the optical density (OD) at 600 nm. 
4.2 Freeze-drying 
The ferments harvested at middle stationary phase were subsequently formulated 
and freeze-dried and the seven batches that were run were of varying freeze-drying 
quality. Some batches were considered “collapsed”, by visual inspection right out 
of the freeze-drier; these samples were partly yellow-brownish in color and had 
hollow spaces with a melted look. This means that the freeze-drying was incom-
plete, the bacterial glass did not form to adequate extension and so more water was 
trapped left in the bacterial cakes. The evidently collapsed batches were batch 1, 5 
and a part of batch 7. The freeze-drier LyoStar II™ seemed to have done a good 
job on batch 2 which was one of the, if not the most stable batch. This machine 
also produced the least stable collapsed batch; batch 1. However, this was no sur-
prise since the automatic program failed during drying of batch 1 and so the 
freeze-drying ceased for a long while before it was restarted.  
Although there was quite a lot of variation in quality between freeze-dried 
samples in many batches (this was mitigated by duplication and selection of the 
most average samples), batch 7 was exceptionally variable because it was parted in 
very well-dried cakes and collapsed cakes. Therefore, it was treated as two batch-
es: “batch 7 collapsed” and “batch 7 dry”. However, only batch 7 dry was used in 
statistical analysis and for finding a correlation between stability in accelerated 
storage and freeze-thaw survival. Batch 7 collapsed was only plotted on the 
CFU/mL graphs (Figures 6 and 7) to see if it behaved like the other collapsed 
batches, which it did.  
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4.3 Survival in accelerated storage assay 
The CFU/mL values observed throughout the accelerated storage assay are shown 
in Figures 6-8. Additionally, the individual CFU/ml values of the bacterial formu-
late before freeze-drying (which are represented graphically in Figures 6-8 at 
timepoint “-5”) have been averaged for each respective treatment (A-C) in Table 
3. The collapsed batches, labeled in Figures 6-8, showed much lower storage-
stability than the non-collapsed batches. There was a large between-batch variation 
of storage-stability, however, treatment C clearly showed higher storage-stability 
than the other treatments. According to Table 3, the cell density before freeze-
drying depended on treatment in the falling order: C > B > A, however, Table 3 
also shows that CIs of the cell density values are too broad for making statistically 
confident statements about this relation, except for the relation between treatments 
A and C. The relation of cell density before freeze-drying of treatment B toward 
the other treatments remains somewhat uncertain, although it was consistent with 
the trend C > B > A in five out of seven possible comparisons. 
 
Figure 6. Storage-stability of L. reuteri cultivated at 37 °C, pH 4.5 represented as CFU/mL over time 
during accelerated storage assay at 37 °C for up to 29 days. The snowflake at “-5” days indicates the 
start of the freeze-drying, at day 0 accelerated storage was started. The values at day -5 are the before 
freeze-dry cell counts and those at day 0 are the initial freeze-drying survival cell counts. 
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Figure 7. Storage-stability of L. reuteri cultivated at 32 °C, pH 4.5 represented as CFU/mL over time 
during accelerated storage assay at 37 °C for up to 29 days. The snowflake at “-5” days indicates the 
start of the freeze-drying, at day 0 accelerated storage was started. The values at day -5 are the before 
freeze-dry cell counts and those at day 0 are the initial freeze-drying survival cell counts. 
 
Figure 8. Storage-stability of L. reuteri cultivated at 32 °C, pH 6.5 represented as CFU/mL over time 
during accelerated storage assay at 37 °C for up to 29 days. The snowflake at “-5” days indicates the 
start of the freeze-drying, at day 0 accelerated storage was started. The values at day -5 are the before 
freeze-dry cell counts and those at day 0 are the initial freeze-drying survival cell counts. 
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Table 3. The average cell densities of the bacterial formulate before freeze-drying for each of the 
treatments with the respective confidence interval and sample sizes 
treatment average cell density of 
formulate (CFU/mL) 
95% confidence 
interval 
sample size 
A; (37 °C, pH 4.5) 2.03×109 ± 1.74×109 5 
B; (32 °C, pH 4.5) 3.64×109 ± 1.74×109 5 
C; (32 °C, pH 6.5) 6.45×109 ± 1.95×109 4 
Rough predictions about the storage-stability could often be made from the look of 
the freeze-dried bacterial cakes. Especially the collapsed batches, exhibited dra-
matically lower storage-stability. When the samples were fresh out of the freeze 
dryer, in the case of well-dried samples, the cake was white and homogenous and 
without any hollow cracks, in contrary to collapsed samples (unfortunately no 
picture was taken of freshly dried collapsed samples). The best well-dried samples 
kept their original look for a long time in accelerated storage as exemplified on the 
right side of Figure 9 E. In contrary, collapsed samples quickly shrinked and be-
came discolored, or changed into a foam during accelerated storage as seen in 
Figure 9. Medium-well-dried samples (of non-collapsed batches, picture not 
shown) would shrink to a moderate extent but kept their dry look and the white 
color for many weeks and had a relatively good storage-stability.  
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Figure 9. Visual inspection of the different looks of collapsing of freeze-dried cakes of Lactobacillus 
reuteri with a well-dried sample represented in picture E (right side). (A) “batch 1 collapsed” after 3 
days of accelerated storage; (B) “batch 1 collapsed” after 3 days of accelerated storage; (C) “batch 1 
collapsed” after 2 weeks of accelerated storage; (D) “batch 7 collapsed” after 4 days of accelerated 
storage; (E) “batch 7 collapsed” (left) and “non-collapsed” (right) after 4 days of accelerated storage. 
A B 
C 
D E 
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The collapsed samples were observed to develop in a few different ways during 
accelerated storage. Two different types of collapses in batch 1 can be seen in 
Figure 9 A and B. In Figure 9 A, the cake has shrinked a lot and become brownish 
in color and moist. It corresponds to treatment B (32 °C pH 4.5). In Figure 9 B, the 
sample is white, voluminous and looks like a foam. It corresponds to treatment C 
(32 °C pH 6.5). Both of these types of collapses led to very low stability – the 
survival rates were close to zero after 1-2 weeks of accelerated storage. Figure 9 C 
shows samples corresponding to all three treatments (A-C) from the collapsed 
batch 1 after 14 days of accelerated storage; interestingly it shows that biomass 
from treatment C (32 °C pH 6.5) collapsed in the white, foamy way while samples 
from the other two treatments have gained a “crumbled”, dry and hollowed-out 
look. The latter type corresponds to a later stage of deterioration of the shrinked, 
darkened and moist samples from Figure 9 A.  
Collapsed samples from other batches showed similar looks during storage to 
what was observed in batch 1, as exemplified in Figure 9 D where collapsed sam-
ples of batch 7 belonging to treatment A exhibit a foamy (left) and a shrinked and 
discolored but dry appearance (right). Another collapsed sample of batch 7 be-
longing to treatment A that exhibits a shrinked, discolored and moist appearance is 
seen in the left part of Figure 9 E. The shrinked and discolored but dry sample type 
had much better storage-stability and never went into the “crumbled” stage as did 
the shrinked, darkened and moist type. It also had much better storage-stability 
than the foamy type. 
It was observed in many batches that different treatments could lead to differ-
ent developments of collapsed samples and even different tendencies towards col-
lapsing at all during freeze-drying. This is summarized in Table 4 below. Treat-
ment A seemed least robust – it showed the greatest variability in appearance 
when collapsed, this tendency was best represented in batch 5 and 7 (Table 4). As 
it already has been demonstrated, treatment C led to the highest storage-stability. 
Furthermore, as can be deduced from Table 4, the superiority of treatment C was 
preserved even in collapsed conditions. The relation in storage-stability between 
treatments A and B was more subtle. To clarify the relation in storage-stability 
between treatments A and B, Figure 10 shows within-batch comparisons of sur-
vival fractions (CFU/mL at a given time divided by initial CFU/mL) after treat-
ment A (represented by rhombus marks) and treatment B (represented by square 
marks). Each batch is represented by a unique color. Treatment A was normally 
more stable than treatment B (see non-collapsed batches, Figure 10) but in col-
lapsed batches it became equivalent to treatment B (batch 1, Figure 10) or worse 
than treatment B (batch 5, Figure 10). It is most likely that treatment A would have 
been worse or equivalent to treatment B also in “batch 7 collapsed” (see Figure 
10), if the foamy samples had not been excluded from measurements. These were 
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excluded because of experience from batch 5, where such samples showed ex-
tremely low storage-stability, while it was meant to use the most “average” sam-
ples from each batch. 
Table 4. Summary of the connections between freeze-drying success, appearance of samples during 
accelerated storage and the storage-stability 
Batch Treatment A Treatment B Treatment C Stability 
Batch 1 (col-
lapsed) 
Shrinked and 
darkened, hard to 
dissolve 
Shrinked and 
darkened, hard to 
dissolve 
Foamy C > A/B 
Batch 2 
 
Looks good Looks good 
(slightly nicer – 
but stability 
worst) 
Looks good C > A > B 
Batch 4 Looks good, 
shrinked more, 
harder to dissolve 
- Looks good, 
shrinked less 
C > A 
Batch 5 
(collapsed) 
Looks much 
worse, parted 
50/50 into foamy 
and shrinked, 
darkened 
Looks better, 
never foamy, 
shrinked less 
- B > A 
(half of meas-
ured A-samples 
were foamy!) 
Batch 6  
 
 
- Looks very nice Looks very nice C > B 
Batch 7 
(collapsed) 
All types of 
collapsing repre-
sented, some are 
foamy 
Never foamy - A > B 
(foamy A-
samples exclud-
ed from viable 
counting!) 
Batch 7 
(dry) 
Looks very nice 
 
Looks very nice 
(fewer uncol-
lapsed samples 
than A) 
 
- A > B 
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Figure 10. Survival of Lactobacillus reuteri subjected to accelerated storage assay at 37 °C for up to 
29 days; within-batch pairwise comparisons between cultivation preconditioning: treatment A (37 
°C, pH 4.5) versus treatment B (32 °C, pH 4.5). Batch 7 contained both well-dried and collapsed 
assemblies of samples. 
So far, the storage-stability of samples from the different fermentation treatments 
(A-C) has been presented as raw data and related to quality of the freeze-drying 
process and the appearance of freeze-dried samples. The storage-stability data was 
further processed statistically in the form of survival fractions through ANOVA 
followed by post-hoc Tukey HSD tests. The results, obtained from both non- and 
log10-transformed data, are represented graphically in Figure 11 as the batch-
adjusted means with 95% CIs. The exact sizes of differences between means along 
with p-values of the statistical tests are presented in Table 5, while the exact num-
bers behind what was plotted in Figure 11 can be found in Tables 6 and 7, along 
with other useful descriptive statistics. p-values from Tukey-HSD which were just 
slightly above the 0.05 threshold were also judged as significant since it was tested 
that cdfTukey (see Materials and methods section 3.5) always gives slightly higher 
p-values than SPSS would.  
A clear and rather consistent trend of falling survival rates is seen in Figure 11 
and the relation between treatments is quite clear. Biomass of fermentation treat-
ment C (32 °C pH 6.5) was easily the most stable, in all cases. The relation be-
tween treatments A (37 °C pH 4.5) and B (32 °C pH 4.5) was, as mentioned, more 
subtle. The plots have been parted in a “reliable” and “unreliable” region. This was 
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done to symbolize some facts: firstly, it indicates where the homogeneity of vari-
ance assumption was kept best. Secondly, it is where the coefficient of variation 
(CV) was lowest (see Tables 6 and 7 below).  
 
 
 
Figure 11. Storage-stability analysis of Lactobacillus reuteri, fermented at three different cultivation 
conditions (rightmost labels). Analyzed by ANOVA and Tukey-HSD, using non-transformed (graph 
A) and log10-transformed (graph B) data of survival in accelerated storage assay during four weeks, 
respectively. Rectangle markers indicate treatment means (batch-adjusted). The cross markers indi-
cate non-adjusted values of individual biological replicates i.e. of individual batches (see Tables 6 
and 7). Bars indicate 95% CI from pooled standard deviation of the adjusted means. Colored stars 
indicate statistically significant differences (p ≤ 0.05) from means of that color. Reliable/unreliable 
region indicates the range of compliance with statistical assumptions and reasonable batch-adjusted 
mean-values. Timepoints at the x-axis are approximate (±1 day). 
A 
B 
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Probably as the consequence of lower CV, the statistically significant differences 
were found in the “Reliable regions”. The CV is a relative, unitless measure of 
how much variance there is in what is measured - relative to the mean (Fay, 2013), 
CV = standard deviation/mean. By looking at Tables 6 and 7, it can be seen that 
the CV starts low but increases with time for non-transformed data and the oppo-
site is true for log10-transformed data. Thirdly, at two weeks and onward is where 
slightly negative adjusted means for non-transformed data appear in the analysis. 
This is unrealistic, yet affects the significance.  
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Table 5. Statistical evaluation of survival in accelerated storage assay for up to four weeks of Lacto-
bacillus reuteri fermented at three different treatments. Only data belonging to “reliable regions” is 
shown (see Figure 11). Differences between block-adjusted means of “raw” survival fractions and 
log10-transformed survival fractions are shown with their corresponding significance p-values from 
the ANOVA and Tukey HSD test. Highlighted in green are significant findings (p ≤ 0.05) and these p-
values are marked with a “*”. Tukey HSD p-values slightly above the 0.05 threshold are also judged 
significant and marked with a “~*” as well as highlighted in green. Timepoints are approximate (±1 
day) 
Timepoint 
and 
ANOVA sig. 
 
Treatment (I) 
 
Treatment(J) 
Difference between 
adjusted means  
(I - J) 
 
Tukey HSD sig. 
Reliable region using non-transformed data 
“ini”raw 
ANOVA: 
p=0.405 
32°C pH 6.5 32°C pH 4.5 0.3735 p= n/a 
32°C pH 6.5 37°C pH 4.5 -0.1412 p= n/a 
37°C pH 4.5 32°C pH 4.5 0.5147 p= n/a 
     
“3day”raw 
ANOVA: 
p= 0.042 * 
32°C pH 6.5 32°C pH 4.5 0.5628 p= 0.051 ~* 
32°C pH 6.5 37°C pH 4.5 0.6035 p= 0.043 * 
37°C pH 4.5 32°C pH 4.5 -0.0407 p= 0.952 
     
“1week”raw 
ANOVA: 
p= 0.045 * 
32°C pH 6.5 32°C pH 4.5 0.3782 p= 0.056 ~* 
32°C pH 6.5 37°C pH 4.5 0.2765 p= 0.151 
37°C pH 4.5 32°C pH 4.5 0.1017 p= 0.772 
 
Reliable region using log10-transformed data 
“2week”log10 
ANOVA: 
p= 0.035 * 
32°C pH 6.5 32°C pH 4.5 3.7652 p= 0.032 * 
32°C pH 6.5 37°C pH 4.5 3.0854 p= 0.052 ~* 
37°C pH 4.5 32°C pH 4.5 0.6798 p= 0.663 
     
“3week” log10 
ANOVA: 
p= 0.254 
32°C pH 6.5 32°C pH 4.5 3.1772 p= n/a 
32°C pH 6.5 37°C pH 4.5 1.4471 p= n/a 
37°C pH 4.5 32°C pH 4.5 1.7301 p= n/a 
     
“4week” log10 
ANOVA: 
p= 0.054 
32°C pH 6.5 32°C pH 4.5 4.5819 p= 0.044 * 
32°C pH 6.5 37°C pH 4.5 1.3724 p= 0.464 
37°C pH 4.5 32°C pH 4.5 3.2095 p= 0.102 
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Table 6. Quantitative statistics from survival of Lactobacillus reuteri during accelerated storage 
assay for up to four weeks, after fermentation at three different treatments. Means represent survival 
fraction, adjusted means have been batch-adjusted through a block design in SPSS. 95% CI are the 
confidence intervals. Abs(Average CV) is the absolute of the coefficient of variation, averaged for all 
treatments. Statistically significant and non-significant results of the omnibus ANOVA test (p=0.05) 
are indicated by “sig” and “n/s”, respectively. Timepoints are approximate (±1 day) 
Time- 
point 
Treatment Biol. 
repl. 
Adjusted 
means 
(EMMs) 
Unadjusted 
means 
95% CI (adjusted 
means) 
Pooled std. 
dev. (ad-
justed 
means) 
Aver-
age 
CV lower upper 
Ini 
(n/s) 
37°C pH4.5 4 1.074 1.016 0.429 1.720  
0.502 
 
0.587 32°C pH4.5 4 0.559 0.608 -0.086 1.205 
32°C pH6.5 4 0.933 0.923 0.288 1.579 
         
3day 
(sig) 
37°C pH4.5 3 0.225 0.178 -0.094 0.543  
0.173 
 
0.394 32°C pH4.5 3 0.265 0.250 -0.053 0.584 
32°C pH6.5 3 0.828 0.848 0.510 1.146 
         
1week 
(sig) 
37°C pH4.5 4 0.155 0.125 -0.045 0.355  
0.156 
 
0.732 32°C pH4.5 4 0.053 0.051 -0.146 0.253 
32°C pH6.5 4 0.432 0.456 0.232 0.632 
         
2week 
(n/s) 
37°C pH4.5 3 0.060 0.0170 -0.212 0.333  
0.149 
 
1.637 32°C pH4.5 3 -0.013 0.0008 -0.285 0.260 
32°C pH6.5 3 0.226 0.2251 -0.047 0.498 
         
3week 
(n/s) 
37°C pH4.5 2 0.063 0.017 -0.188 0.315 0.082 
0.082 
0.076 
 
2.000 32°C pH4.5 2 -0.037 0.001 -0.289 0.214 
32°C pH6.5 3 0.093 0.093 -0.095 0.280 
         
4week 
(n/s) 
37°C pH4.5 3 0.016 0.00510 -0.036 0.068  
0.028 
 
2.000 32°C pH4.5 3 -0.008 0.00007 -0.060 0.044 
32°C pH6.5 3 0.034 0.03532 -0.018 0.086 
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Table 7. Quantitative statistics from survival of Lactobacillus reuteri during accelerated storage 
assay for up to four weeks, after fermentation at three different treatments. Means represent 
log10(survival fraction), and were batch-adjusted through a block design in SPSS. 95% CI are the 
confidence intervals. Abs(Average CV) is the absolute of the coefficient of variation, averaged for all 
treatments. Statistically significant and non-significant results of the omnibus ANOVA test (p=0.05) 
are indicated by “sig” and “n/s”, respectively. Timepoints are approximate (±1 day) 
Time- 
point 
Treatment Biol. 
repl. 
Adjusted 
means 
(EMMs) 
95% CI (adjusted 
means) 
Pooled std. 
dev.  
(adjusted 
means) 
Abs(Average 
CV) 
lower upper 
Initial 
(n/s) 
37°C pH4.5 4 -0.054 -0.439 0.331  
0.300 
 
2.206 32°C pH4.5 4 -0.294 -0.679 0.091 
32°C pH6.5 4 -0.059 -0.444 0.326 
        
3day 
(n/s) 
37°C pH4.5 3 -0.859 -1.873 0.155  
0.553 
 
0.892 32°C pH4.5 3 -0.936 -1.950 0.078 
32°C pH6.5 3 -0.064 -1.078 0.950 
        
1week 
(n/s) 
37°C pH4.5 4 -2.349 -3.835 -0.863  
1.156 
 
0.713 32°C pH4.5 4 -1.999 -3.485 -0.513 
32°C pH6.5 4 -0.514 -2.000 0.972 
        
2week 
(sig) 
37°C pH4.5 3 -4.072 -5.829 -2.314  
0.956 
 
0.292 32°C pH4.5 3 -4.752 -6.509 -2.994 
32°C pH6.5 3 -0.986 -2.744 0.771 
        
3week 
(n/s) 
37°C pH4.5 2 -3.099 -7.696 1.498 1.510 
1.510 
1.379 
 
0.459 32°C pH4.5 2 -4.829 -9.426 -0.232 
32°C pH6.5 3 -1.652 -5.078 1.775 
        
4week 
(border 
case sig.) 
37°C pH4.5 3 -3.658 -6.092 -1.224  
1.325 
 
0.310 32°C pH4.5 3 -6.867 -9.301 -4.434 
32°C pH6.5 3 -2.285 -4.719 0.148 
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4.4 Freeze-thaw assay survival 
Survival fractions of the FT assay, according to fermentation treatment used, are 
shown below in Figure 12. The best survivor was after fermentation at treatment B 
(32 °C, pH 4.5) followed by treatment A (37 °C, pH 4.5). The drastically worst 
survivor was after treatment C (32 °C pH 6.5).  
Statistical analysis of the FT-assay survival data with ANOVA followed by 
Tukey-HSD revealed that the mean survival of FT assay after treatment C differed 
significantly (at p-value below 0.05) from the mean survival of the other two 
treatments, when using log10-transformed data but not non-transformed data, see 
Table 8. Additional quantitative statistics data is provided in Table 9, where it can 
be seen that the CV of log10-transformed data is much lower than that of non-
transformed data, and this explains the greater power of the statistical tests for the 
log10-transformed dataset.  
 
Figure 12. Freeze-thaw assay survival of Lactobacillus reuteri fermented at three different treat-
ments: (A) 37 °C pH 4.5; (B) 32 °C pH 4.5 and (C) 32 °C pH 6.5. Results based on log10-
transformed data. The rectangular markers represent the treatment means (batch adjusted), the bars 
show 95% CIs and the black cross markers represent the individual biological replicates (batches). 
The colored stars next to the CI bar indicate a statistical difference between the mean and the means 
of the stars colors. 
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Table 8. Statistical evaluation of freeze-thaw assay survival of Lactobacillus reuteri fermented at 
three different treatments. Differences between block-adjusted means of survival fractions are shown 
together with their corresponding significance p-values from the ANOVA and Tukey HSD multiple-
comparisons test. Highlighted in green are significant findings (p ≤ 0.05) and these p-values are 
marked with a “*”. Tukey HSD p-values slightly above the 0.05 threshold are also judged significant 
and marked with a “~*” as well as highlighted in green 
Type of data 
(FT assay  
survival) 
ANOVA 
omnibus test 
 
Treatment (I) 
 
Treatment (J) 
Survival  
mean diff.  
(I - J) 
Tukey HSD 
significance: 
Non-transformed 
 
 
p=0.100 
32°C pH 6.5 32°C pH 4.5 -0.0744 p=0.090 
32°C pH 6.5 37°C pH 4.5 -0.0272 p=0.616 
37°C pH 4.5 32°C pH 4.5 -0.0472 p=0.273 
 
log10- 
transformed 
 
 
p=0.030 * 
32°C pH 6.5 32°C pH 4.5  2.3984 p=0.026 * 
32°C pH 6.5 37°C pH 4.5  1.8768 p=0.054 ~* 
37°C pH 4.5 32°C pH 4.5  0.5216 p=0.674 
 
Table 9. Quantitative statistics for FT assay survival of Lactobacillus reuteri fermented at three 
different treatments. Means represent survival fraction/log10(survival fraction), according to type of 
data. 95% CI are the confidence intervals. Abs(Average CV) is the absolute of the coefficient of 
variation, averaged for all treatments. Statistically significant and non-significant results of the 
omnibus ANOVA test (p=0.05) are indicated by “sig” and “n/s”, respectively 
Type of 
data 
Treatment No. of 
biol. 
repl. 
Unadjusted 
means  
 
Adjusted 
means 
(EMMs) 
 
95% CI (adjusted 
means) 
Pooled 
std. dev. 
(adjusted 
means) 
Average 
CV 
lower upper 
Non- 
transf. 
(n/s) 
37°C pH4.5 4   0.0090 0.013 -0.032 0.058 0.032  
1.678 32°C pH4.5 4   0.0598 0.060  0.015 0.105 0.032 
32°C pH6.5 3   0.0002    -0.014 -0.069 0.041 0.035 
         
Log10 
transf. 
(sig) 
37°C pH4.5 4     -2.162 -2.102 -3.058 -1.146 0.688  
 0.275 32°C pH4.5 4     -1.552 -1.580 -2.536 -0.624 0.688 
32°C pH6.5 3     -3.833 -3.979 -5.146 -2.811 0.727 
4.5 Correlating survival of freeze-thaw and accelerated storage 
assays 
The survival of L. reuteri after one and two weeks in the accelerated storage assay 
was plotted against its survival of the FT-assay in Figures 13 and 14, respectively. 
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In both cases, a negative trend was seen; higher FT-assay survival meant lower 
storage-stability. The negative slope was steeper after two weeks because natural-
ly, more cells had died after an additional week of accelerated storage. Batch 5 
was included in these plots but specifically labeled, since it seemed to be quite an 
outlier. It is the only collapsed batch in this part of the analysis because for each of 
the plots, only those batches were used for which there was data for both storage-
stability and FT-assay survival (and FT-survival had not been measured for batch 
1 with the appropriate assay procedure). Therefore, the correlated storage-
stability/FT-assay survival means belonging to each of the three fermentation 
treatments (A-C), plotted in Figures 13 and 14, do not include batch 1 (and Figure 
13 does not include batch 7 due to the experimental design). The correlated means 
were not batch-adjusted. See Tables 6 and 9 in the previous sections to compare 
with both batch-adjusted and unadjusted means when including all available 
batches.  
The mean stability after 1 week was plotted versus the negative 10-logarithm of 
mean FT-assay survival for each treatment, in order to fit a line and get a predic-
tive equation (Figure 15). Only batches for which both storage-stability and FT-
assay survival data was available were included, except for batch 5 which was 
excluded in this case. The formula behind the fitted line, y = 0.0901x1.336, is a 
power equation. The FT-assay survival was transformed by (– log10) to avoid neg-
ative signs in the equation. For additional information, including batch 5 gave the 
equation: y = 0.0224x2.43. This could perhaps be a useful, more robust but less 
precise prediction if one anticipates some batches to be collapsed. At week 2 and 
not including batch 5, the equation became y = 0.0004x5.1119 (steeper). See Discus-
sion section regarding conclusions about using FT-assay as a predictor of stability. 
Note that to use these equations, the “x” must be provided as the negative log10 of 
FT-assay surviving fraction. 
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Figure 13. Correlation between survival of Lactobacillus reuteri after 1 week in accelerated storage 
assay and its survival of freeze-thaw assay. Using unadjusted means, data from a combination of 
batches 2, 4, 5 and 6. Cross-markers indicate the correlated average for each treatment and the other 
markers indicate measurements from individual batches. 
 
Figure 14. Correlation between survival of Lactobacillus reuteri after 1 week in accelerated storage 
assay and its survival of freeze-thaw assay. Using unadjusted means, data from a combination of 
batches 4, 5, 6 and 7(dry). Cross-markers indicate the correlated average for each treatment and the 
other markers indicate measurements from individual batches. 
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Figure 15. Correlation between survival of Lactobacillus reuteri after 1 week of accelerated storage 
and the negative logarithm (base 10) of its freeze-thaw assay survival. Unadjusted values, combina-
tion of batches 2, 4 and 6 (batch 5 not included).   
4.6 Statistics 
The ANOVAs and Tukey-HSD tests that were used to statistically evaluate the 
difference between survival means in the FT and accelerated storage assays were 
based on a statistical model with some assumptions (see Background section 
2.6.1). The following subsections describe how well these statistical assumptions 
were fulfilled.  
4.6.1 Assumptions of statistical tests – normality 
An example of the normal Q-Q plots of standardized residuals which were plotted 
for each ANOVA and compared between non-transformed and log10-transformed 
data is shown in Figure 16. The rest of the plots can be found in Figures 23 and 24 
in Appendix. The normal Q-Q plots allow the reader to judge by eye and experi-
ence how well the residuals fit the normality assumption of ANOVA. The closer 
to the line the dots are, the better. Also, it is better if the dots are randomly scat-
tered around the line instead of forming curves. The graphical information is rep-
resented in Table 10 in the quantitative form of skewness, kurtosis and the results 
of Shapiro-Wilk test; which is easier to judge objectively.  
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Figure 16. Normal Q-Q plots of expected residuals for normal distribution versus observed residuals, 
for evaluation of the normality assumption of ANOVA in the freeze-thaw (FT) assay. Plots based on 
non-transformed (raw) and log10-transformed data are compared side by side. Each plot contains the 
combined standardized residuals of all the biological replicates for all treatments and batches. 
Table 10. Statistical significances (sig.) of Shapiro-Wilk test and the skewness and kurtosis compared 
to their respective standard errors. The underlying data is for each ANOVA (non-transformed 
=”raw” or log10-transformed) the combined standardized residuals for all treatments and batches 
Accelerated storage assay 
Timepoints (±1day) 
Freeze-
thaw 
assay 
Type of 
evaluation 
Ini 
raw 
3day 
raw 
1week 
raw 
2week 
raw 
3week 
raw 
4week 
raw 
FT-assay 
raw 
Shapiro-
Wilk, sig. 
0.970 0.505 0.197 0.468 0.394 0.802 0.776 
Skewness / 
Std error 
-0.501 /                
0.637 
0.603 / 
0.717 
-0.005 / 
0.637 
-0.339 / 
0.717 
0.267 / 
0.794 
-0.075 / 
0.717 
0.448 / 
0.661 
Kurtosis / Std 
error 
0.210 / 
1.232 
-0.789 / 
1.400 
-1.669 / 
1.232 
-0.419 / 
1.400 
-1.427 / 
1.587 
-1.082 / 
1.400 
-0.598 / 
1.279 
Type of 
evaluation 
Ini 
Log10 
3day 
Log10 
1week 
Log10 
2week 
Log10 
3week 
Log10 
4week 
Log10 
FT-assay 
Log10 
Shapiro-
Wilk, sig. 
0.700 0.839 0.680 0.657 0.393 0.606 0.600 
Skewness / 
Std error 
 
-0.647 / 
0.637 
0.405 / 
0.717 
0.738 / 
0.637 
0.141 / 
0.717 
-0.361 / 
0.794 
-0.281 / 
0.717 
0.010 / 
0.661 
Kurtosis / Std 
error 
0.293 / 
1.232 
-0.816 / 
1.400 
0.244 / 
1.232 
-1.447 / 
1.400 
-1.382 / 
1.587 
-1.150 / 
1.400 
-1.029 / 
1.279 
From the Shapiro-Wilk test of normality (Table 10), there were no cases close to 
significantly violating normality at 95% probability (p ≤ 0.05) which can be seen 
FT-assay raw FT-assay log10 
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also from the fairly good looking Q-Q plots in which only pattern-formation some-
times looked a little suspect but not the general trend. There is no clear difference 
in how well the residuals of log10-transformed or non-transformed data follow 
normal distribution which is also seen in the values of skewness and kurtosis (Ta-
ble 10). Sometimes, transformed data is better and sometimes non-transformed 
data is better. A rule of thumb for acceptable skewness and kurtosis for the normal 
distribution (IBM Knowledge Center - Display Statistics) says that the absolute 
value of skewness should be less than twice its standard error (compared in Table 
10) and the same goes for the absolute value of kurtosis. There were no cases close 
to these borders. Therefore, adequate normality of error distribution was assumed.  
4.6.2 Assumptions of statistical tests - Homogeneity of variance 
 
The standardized residuals of each ANOVA of the accelerated storage assay and 
FT-assay were plotted versus treatments (Figure 17 and Figures 25 and 26 in Ap-
pendix) to assess the second assumption of ANOVA, homogeneity of variance. It 
is the relative homogeneity of residual variance (similarity of spread) between 
treatments and not absolute values that is judged, so the scale on the y-axis in 
these figures is not important. The numerical values in textboxes in the plots show 
the ratio between the widest and narrowest variances. By looking at Figures 25-26 
in Appendix it can be seen that for the “ini” timepoint (initial survival), there is no 
notable difference in this ratio between log10-transformed and non-transformed 
data. After that, the non-transformed data gives more homogenous variances until 
2 weeks. Starting at two weeks and forward, the log10-transformed data gives most 
homogenous variances. For the freeze-thaw assay, in which survival rates were 
similar to the 2 weeks timepoint in accelerated storage assay, the log10-transformed 
data gives most homogenous variance of residuals (Figure 17). This could mean 
that an ANOVA will be more reliable when performed on non-transformed data 
until 1 week of accelerated storage is reached and after that (and for the FT-assay), 
log10-transformed data will yield the most reliable ANOVA. Following this con-
clusion and using transformed and non-transformed data for the ANOVAs accord-
ingly, the homogeneity of variance assumption seems largely fulfilled, according 
to the rule of thumb (see Background section 2.6.1) with the exception of the 
timepoint at 3 weeks. This case, however, had very small sample size (and the 
sample size was unequal between fermentation treatments) due to missing data.  
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Figure 17. Standardized residuals versus treatments, where treatment no. 1 = 37 °C, pH 4.5; 2 = 32 
°C, pH 4.5; 3 = 32 °C, pH 6.5. Freeze-thaw assay, comparison of non-transformed (raw) and log10-
transformed data, respectively. Ratio of widest variance over narrowest variance is shown in the 
textboxes. 
4.7 Microscopy 
The microscopic studies revealed many differences in morphology of L. reuteri 
resulting from the different fermentation conditions (treatments A-C). Treatment 
A led to short cells, treatment B to medium-length cells and treatment C tended to 
lead to long cells. The variance between the shortest and longest cell observed 
seemed to follow the same increasing trend with few exceptions. Treatment A and 
B gave cell chains and cell clumps while treatment C gave fewer chains and no 
clumps at all. These findings are represented by three example photographs from 
the respective treatments (A-C) in Figure 18, while photos from the rest of the 
batches can be found in Figure 28 in Appendix. Furthermore, Table 11 summariz-
es the morphology observations. The cell sizes in Table 11 have been recalculated 
into µm using the objective micrometer scales seen at the photographs, with the 
help of Figure 27 in Appendix. 
 
FT-assay 
raw 
FT-assay 
log 
1.3 
(better) 
2.5 
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Figure 18. Cultures of Lactobacillus reuteri grown 
at three different fermentation treatments (A-C), 
viewed at around harvest time. The blue rings help 
to spot cell clumps. Objective micrometers show the 
scale which is recalculated into µm using Figure 27 
in Appendix. Viewed in phase-contrast microscopes 
at 1000X magnification. See Table 11 for which 
microscope was used for each photo. 
(A) Grown at 37 °C, pH 4.5; batch 5. 
(B) Grown at 32 °C, pH 4.5; batch 5. 
(C) Grown at 32 °C, pH 6.5; batch 4. 
Table 11. Summarized microscopic morphology observations of Lactobacillus reuteri grown at three 
different fermentation treatments (A-C); A = 37 °C, pH 4.5; B = 32 °C, pH 4.5; C = 32 °C, pH 6.5 
Treatment Batch Average cell 
size (µm) 
Variation in 
cell size (µm) 
Chains Clumps Microscope 
A 
 
4 2.1  1.2-2.4  
 
Some dual Yes Local lab 
A 
 
5 2.1  1.3-2.7  
 
Some dual  
& longer 
Yes (a lot) Course lab 
A 
 
7 2.11  1.9-4.31 
 
Some dual Yes (a lot) Course lab 
B 5 2.6 1.9-6.7 
 
Some dual 
 
Yes Course lab 
B 6 2.6 1.6-2.8 
 
A lot of different 
chains2 
Yes Course lab 
B 7 3.0 1.7-6.2 
 
Most dual, few 
longer 
Yes, small Course lab 
A B 
C 
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Treatment Batch Average cell 
size (µm) 
Variation in 
cell size (µm) 
Chains Clumps Microscope 
C 
 
4 7.1 2.0-15.8 
 
Few dual No Local lab 
C 
 
6 5.0 1.8-11.2 Few dual No Course lab 
1. Scale is lacking at this photo but it was compared with a later photo of formulated biomass from same 
batch which had a scale and looked similar.  
2. Microscopy was very delayed after sampling (3h) and it was observed from later microscopy studies that 
chains evolve while keeping the samples on hold. 
When it comes to microscopy observations of Gram-stained samples, there was no 
consistent difference in staining between fermentation treatments 37 °C, pH 4.5 
and 32 °C, pH 4.5. Staining these resulted in anything between all cells red to 70% 
blue cells (Table 12). The fermentation treatment 32 °C, pH 6.5 did stand out 
against the other two dramatically in being stained completely blue; however, 
staining of this treatment was not replicated (since Gram-staining was implement-
ed at batch 5, leaving only one opportunity to stain cells from this fermentation 
treatment).  
There was on the other hand an association of Gram-stain results with batch 
number; the batches replicated in Gram staining (although for different treatments) 
were batch 5, 6 and 7. It seems that batch 5 stained 50/50 red/blue, batch 6 stained 
strongly blue and batch 7 stained strongly red irrespectively of treatment (Table 
12). The actual microscopy photos of all Gram-stained samples are found in Fig-
ure 29 in Appendix. 
The Gram-stain results were also compared with the relative storage-stabilities 
within treatments (to eliminate the effect of treatment on storage-stability) and the 
batch quality (collapsed or non-collapsed) and this is summarized in Table 12 
below. The relative within-treatment storage-stabilities were judged by comparing 
the CFU/mL curves during accelerated storage (Figures 6, 7 and 8). The percent-
age of blue/red cells after Gram-staining did not correlate with the relative storage-
stability, even when excluding collapsed batches. To illustrate this by examining 
Table 12, consider that “(A) batch 7” consists of all red cells and corresponds to 
2.8×105 CFU/mL after 4 weeks of accelerated storage while “(B) batch 6” consists 
of 70% blue cells but corresponds to only 5.95×102 CFU/mL after 4 weeks. At the 
same time, the 100% blue “(C) batch 6” is extremely storage-stable (7.21×108 
CFU/mL after 4 weeks).    
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Table 12. Comparing Gram-stain of Lactobacillus retueri cultivated at different conditions with 
relative within-treatment storage-stability and with batch quality. Corresponding microscopy photos 
are found in Figure 29 in Appendix 
Photo in Fig. 29 
(Appendix) 
Red/blue cell ratio Relative stability within 
treatment (Figs. 6-8) 
Batch quality 
”(A) batch 5” 50/50 very low Collapsed  
“(A) batch 7” all red above average Good (batch 7 dry) 
“(B) batch 5” 50/50 below average Collapsed  
“(B) batch 6” 70% blue above average Good  
“(B) batch 7” almost all red medium Good (batch 7 dry) 
“(C) batch 6” all blue above average Good  
Trying to gain more understanding about the Gram-stain results, these were com-
pared with the ln(OD) growth-curves (Figures 3-5), fermentation durations, FT-
assay survival and specific events during the fermentation and during the micros-
copy itself (summarized in Tables 13). The Gram-stain did not correlate whatso-
ever to the height of the ln(OD) curves, the cultivation time nor the FT-assay sur-
vival. No trend could be found with how soon after sampling the Gram-stain was 
done nor with the delay of harvest against the cultivation length plan (Material and 
methods, section 3.1.1 “Fermentation and formulation”).The most delayed cases 
were strongly blue, the moderately delayed were strongly red and the least delayed 
were colored 50/50). The only factor that is possible to link with the result of the 
Gram-stain is the batch number.  
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Table 13. The relations between results of observations of Gram-stained Lactobacillus reuteri from 
different cultivations and heights of optical density (OD) curves, harvest time, time from anticipated 
entry into middle stationary phase (MSP) to harvest, delay between sampling to staining and survival 
of freeze-thaw (FT) assay 
Photo in  
Fig. 29 
(Appendix) 
Red/blue 
cell ratio 
growth 
curve 
height 
(Figs. 3-5) 
Inoculum 
to harvest 
(h) 
Delay 
from MSP 
to harvest 
(h:min) 
Microscopy: 
from sam-
pling to 
Gram-stain 
FT assay  
surviving 
fraction 
(and ranking) 
”(A) batch 5” 50/50 
 
Medium 23:08 0:42 quick 0.0079 (4) 
“(A) batch 7” all red 
 
Very low  23:39 1:14 medium 0.0111 (3) 
“(B) batch 5” 50/50 
 
Above   
average 
26:15 0:49 slow 0.0017 (5) 
“(B) batch 6” 70% blue 
 
Very low 26:21 1:34 slow 0.0778 (1) 
“(B) batch 7” almost all 
red 
Medium  26:38 1:11 slow 0.0395 (2) 
“(C) batch 6” all blue 
 
Medium 24:50 2:03 quick 0.0001 (6) 
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In the first attempt to capture GASP mutants by IMC, it was observed that during 
the initial growth phase, whole-MRS medium gave rise to a higher heat flow 
(peaking at about 8.25 mW, Figure 19 A) than half-MRS medium (peaking at 
about 6.15 mW, Figure 19 C) but the shapes of the curves are very similar. Figures 
19 B and D show the development of the heat flows starting from the stationary 
phase and going into the long-term stationary phase, in a very zoomed-in heat flow 
scale since the heat activity was small during this time. The heat flow became 
slightly negative in the stationary phase (more so with whole-MRS, Figure 19 B) 
implying a small endothermic activity; or this was due to positioning of the base-
line. After this dip, the heat flow slowly climbed up during the long-term station-
ary phase, to values near zero heat flow (whole-MRS) or around 5 µW (half-
MRS). No drastic peaks that would evidently imply GASP activity were observed. 
The erratic fluctuations in the long-term stationary phase heat flows usually follow 
exactly the same pattern for all ampoules and therefore must be noise, probably 
due to small external disturbances.  
 
 
 
 
 
5 Results – GASP experiment 
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Figure 19. First attempt of GASP cultivation, each colored line indicates an individual ampoule. A = 
Heat flow curve of whole-MRS-broth L. reuteri during growth phase. B = Heat flow curve of whole-
MRS-broth L. reuteri during long-term stationary phase. C= Heat flow curve of half-MRS-broth L. 
reuteri during growth phase. D = Heat flow curve of half-MRS-broth L. reuteri during long-term 
stationary phase. Note that A and C are in mW scale while B and D are in µW scale. Note also that A 
and C are in hour scale while B and D are in day scale. 
In the second attempt to capture a GASP by IMC, the baseline was not established 
in the best way (see Materials and methods), so the graphs should be viewed with 
some caution. Figure 20 A shows the heat flow during initial growth phase of the 
E. coli in LB broth controls. The graph is from a screenshot, this data was not col-
lected into the “experiment” file in the TAM Air Assistant program because the 
“experiment” was actually started at the beginning of the lag phase (18 hours after 
insertion of samples into the calorimeter). Therefore, the absolute values may be 
biased in this graph. The heat flows during long-term stationary phase of E. coli 
controls (colored lines Figure 20 B) show a dip into negative values at the very 
beginning of the experiment. This dip is very likely explained by the late baseline 
establishment – there must have been some residual heat activity from initial 
growth of the cultures when the baseline was established and this heat flow then 
diminished, giving a negative heat flow reading. Otherwise, not much happened  
  
  
A B 
C D 
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Figure 20. Second attempt of GASP cultivation, each colored line indicates an individual ampoule.        
A = Heat flow curve of E.coli in LB broth during growth phase. B = Heat flow curve during long-
term stationary phase of E. coli in LB broth control (colored lines) and old whole-MRS Lactobacillus 
(gray lines). C = Heat flow curve of L. reuteri in half-MRS-twice-MOPS broth during long-term 
stationary phase. Note that in B and C, day zero is the start of experiment which in this case is at the 
beginning of the stationary phase. The completely vertical heat flow lines seen in picture C are the 
heat flows resulting from retrieval of two ampoules for viable counting. 
with the heat flow of E. coli controls during the long-term stationary phase. As a 
remark however, the patterns of fluctuations were not always identical between the 
different E. coli ampoules. Figure 20 B also shows the heat flows of the very old 
whole-MRS cultures from the previous GASP experiment (gray lines) which had 
been kept incubated at 37 °C for 30 days after the first IMC experiment and 
brought back to IMC for the second experiment. These samples were quite intri-
guing; most of them show a rather strong dip into negative heat flow, some as low 
as -70 mW, after a few days in IMC. Why would these cultures, which had stabi-
B C 
A 
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lized around 0 heat flow during the previous experiment, suddenly drop so low a 
few days after the next experiment was started? 
The behavior of the half-MRS-twice-MOPS Lactobacillus samples during 
long-term stationary phase is shown in Figure 20 C. The heat flow pattern was 
quite similar to that of half-MRS Lactobacillus in the first attempt (Figure 19 D): 
the negative dip reached about -15 µW, then climbed up to a peak of 8 µW after 
11 days (in second attempt, half of the samples peak at 0 µW while the other half 
peak at about 11 µW, after 7 days). After the peak, half-MRS samples in the pre-
vious experiment (Figure 19 D) showed a small depression and then the beginning 
of a new, mild climb at day 15. The half-MRS-twice-MOPS samples (Figure 20 C) 
also showed the small depression followed by a new, mild climb, also starting at 
day 15. This climb seems to continue very vaguely throughout the experiment. 
The results of the VCs done on ampoules retrieved from the calorimeters are 
presented in Table 14 below. After 21 days, the non-buffered samples had lost all 
detectable viability. VC of the MOPS-buffered samples was unfortunately only 
measured after 7 days and at that time exhibited a GASP-like level.  
Table 14. Viable count results of L. reuteri cultivated in different media during the GASP experi-
ments, in which the bacteria were cultivated for a prolonged time in isothermal calorimeters 
Samples – first experiment CFU/mL 
whole-MRS, day 16 
(two ampoules) 
2.3×103 
5.7×103 
 
whole-MRS, day 21 
(two ampoules) 
<102 
<102 
 
half-MRS, day 21 <102 
 
Samples – second experiment  CFU/mL 
half-MRS-twice-MOPS, 
day 7 
(two ampoules) 
1.5×106 
1.9×106 
Additionally, a summary of the pHs in stationary phase of L. reuteri cultivations in 
various media is found in Table 15 below.   
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Table 15. Summary of pH measurements of different media tested with L. reuteri in the “personal 
bioreactor” before the second attempt of GASP cultivation 
Medium Cultivation time pH 
whole-MRS fresh medium 5.53 
whole-MRS 22 days 4.29 
half-MRS 22 days 4.24 
whole-MRS-MOPS fresh medium 6.34 
whole-MRS-MOPS ~24 hours 4.58 
half-MRS-MOPS fresh medium 6.82 
half-MRS-MOPS ~24 hours 4.75 
half-MRS-twice-MOPS fresh medium 7.25 
half-MRS-twice-MOPS 3 days 5.46 
Finally, Figure 21 below shows the growth curve in half-MRS-twice-MOPS medi-
um, measured by the Personal Bioreactor. Growth seemed exponential to perhaps 
the third hour, after which it became rather linear. Similar results were seen in 
(Årsköld et al., 2008) when a different strain of L. reuteri grew on glucose. 
 
Figure 21. Growth curve of a test cultivation in the “personal bioreactor”. The personal bioreactor 
has an OD850 measurment range of 0-8 at 30 mL cultivation, equivalent to OD600 0-19 (RTS-1C, 
Personal bioreactor — Biosan). 
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There was little difference in the VCs when equivalent biomass was resolved in 
either 0.9% or 0.09% saline solution (Figure 22).  
 
 
Figure 22. Viable counts of equivalent biomass when resuspended with different concentrations of 
saline. The rectangular markers are the grand means of the counts. The triangles are the means of the 
individual dilution series. The cross markers are the individual counts. 
Interestingly, the 0.09% solution gave slightly higher viable counts than the stand-
ard solution of 0.9% but the difference was so small that it was far from statistical 
significance, with this amount of measurements. It seems reasonable to say that 
the accidental use of the 0.09% solution for a period of time in the experiments did 
6 Results – Saline test 
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not affect the results or conclusions noticeably. Furthermore, samples of all treat-
ments were treated with the same saline at a given viable count, so the relation 
between treatments should not have changed. 
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7.1 Growth during cultivation 
The observation that exponential growth changed to a linear growth after 2-5 
hours of cultivation (Figures 3-5), time being dependent on fermentation condi-
tions, is similar to what was observed with the strain ATCC 55730 when grown on 
glucose (Årsköld et al., 2008) due to a redox imbalance. Adding sucrose to the 
cultivation media could enhance the growth rate and the yield because it provides 
an external electron acceptor (Årsköld et al., 2008). Perhaps, as in that study, sup-
plementing the medium with sucrose to improve the redox balance would give 
faster growth and better yield. In addition, it could perhaps prepare the cells for the 
subsequent sucrose formulation. It could even precondition the cells for the high 
osmolality during drying, as for example, shown by (Tymczyszyn et al., 2007) 
where sucrose-supplemented MRS medium for cultivation of a different Lactoba-
cillus species improved the drying survival, although the drying method was vacu-
um-drying. As a remark, using fructooligosacharides as the formulant was better 
than sucrose for increasing freeze-dry survival, long-term storage after freeze-dry 
survival and membrane integrity of L. reuteri TMW1.106 (Schwab et al., 2007). 
Finally, it is important to remember that the resistance to gastric juices and 
beneficial health effects of the product can be affected by the whole process start-
ing from cultivation conditions and ending at resuspension of the product. This 
must also be assessed early in the studies, to avoid spending research resources 
towards a potential dead-end. Therefore, it is important to find good and not to 
laborious assays for these qualities and couple them with upcoming optimization 
experiments.  
7 Discussion 
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7.2 Freeze-drying and collapsing 
Regarding the freeze-drying procedures in this study, apparently collapsing and 
variable batch quality were major issues. When it comes to the vacuum level, ac-
cording to (Fonseca et al., 2015) the recommended pressure to reach before the 
primary drying step is 20 Pa. Then, the pressures used in this study seem to have 
been sufficiently low, as the highest cases were 16 Pa (although the pressure gauge 
had low resolution). Unfortunately, the Labconco freeze-drier did not have both a 
Pirani gauge and a capacitance manometer to identify the point of a finished sub-
limation nor was it possible to record the probe (thermocouple) temperature. The 
temperature was tracked during the vacuum pumping and the beginning of the 
primary drying to look for collapse risks. When the samples had been inserted into 
the freeze-drier at a shelf temperature of -40 °C and the vacuum pumping was 
initiated, the temperature of the samples (according to thermocouples) would keep 
rising for as long as 20-30 minutes. In batch 4, the worst-case thermocouple 
showed -32 °C during this phase. However, when the primary drying was initiated, 
the temperatures of the probed samples were below the shelf temperature due to 
sublimation (Fonseca et al., 2015) (-30 to -35 °C versus a shelf temperature of -20 
°C) and increased to above the shelf temperature during the next day, as it is sup-
posed to be when sublimation is finished (Fonseca et al., 2015). In batch 5, the 
temperature of the probes slowly increased (over the course of 28 minutes) from -
40 °C to between -31 and -34 °C during the vacuum pumping. In batch 6, the 
probes stayed at -38 to -41 °C during vacuum pumping. In batch 7, the tempera-
ture increased to between -28 and -33 °C during vacuum pumping. Unfortunately, 
the notes of the temperature behavior during primary drying are lacking in batches 
other than no. 4. Batches no. 1 and 2 were not recorded. In compliance to what 
was written in the Introduction, section 1.2, it can be anticipated that the bacterial 
formulation used in this work had a Tc no less than -24 °C. Perhaps the shelf tem-
perature during primary drying should have been lower to avoid collapse. Howev-
er, the major issue turned out to be that the Labconco machine was in need of ser-
vice and therefore struggled with vacuum pumping. This made the sublimation of 
ice less efficient and therefore increased the collapse risk, since it results in higher 
humidity and temperature around the samples.  
As it is mentioned in (Fonseca et al., 2015), the presence of a thermocouple 
probe in a sample will catalyze its sublimation process. Indeed, in batch 7 in which 
some of the samples were well-dried and the others were collapsed, those that had 
a probe were the best-looking ones (maybe because a higher water content de-
creases Tg’ (Higl et al., 2007), the probed samples dried faster and avoided col-
lapsing). This could be seen as an error source toward the other samples because it 
is an inconsistency in the freeze-drying process and since these samples were most 
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probably the driest, they would have a lower tendency of deteriorating during stor-
age as well. Nevertheless, non-collapsed biomass was scarce in batch 7 and so 
these samples had to be used for the measurements too. These samples also lacked 
vacuum because the thermocouples had to be taken out before closing the corks. 
However, in this study there were a few other cases in which a non-probed sample 
lacked vacuum and could be compared to a duplicate with vacuum. There was no 
consistent trend in the influence of vacuum on storage-stability.  
7.3 The effect of fermentation conditions on storage-stability 
In this study, it was demonstrated that a neutral pH (6.5) during cultivation of L. 
reuteri led to higher storage-stability after freeze-drying than when using lower 
pH, clearly seen in Figure 11. Microscopy revealed that this fermentation treat-
ment also gave rise to an elongated cellular morphology and absence of cell 
clumps. When looking at the more subtle relation between treatments A (37 °C, 
pH 4.5) and B (32 °C, pH 4.5), usually, treatment A gave better storage-stability 
than B but after 3 days (and 1 week in log-transformed data), it was the other way 
around. The reason for the fact that the relation between A and B could change 
between non-transformed and log10-transformed data at timepoints 3 days and 1 
week lies in the procedure of transforming the data; first logarithmizing the tech-
nical replicates, taking their average for each biological replicate and finally let-
ting SPSS calculating the treatment means. In cases where the difference is small, 
this mathematical procedure could turn the relation. Regarding how to interpret 
this in practice, it is suggested to simply trust the “reliable region” on each graph 
(in Figure 11 A and B). However, consultation with a statistician regarding this 
issue would be beneficial. For plotting the correlation of FT assay survival with 
stability in accelerated storage assay, however, the data used was neither batch-
adjusted nor transformed. In conclusion, there was a consistent difference between 
treatments but the low number of replicates and large variance in stability made 
the 95% CIs broad. Still, the treatment of 32 °C, pH 6.5 stood out from the others, 
even significantly. The difference between treatments A and B, although not statis-
tically significant, is supported by a consistent relation in all cases except one ear-
ly timepoint (3 days).  
In a similar study to the present one (Palmfeldt & Hahn-Hägerdal, 2000), L. 
reuteri ATTC 55730 also exhibited elongated cells at pH 6 versus pH 5. Accord-
ing to that study, the relative initial survival after freeze-drying was better at pH 5 
than at pH 6 (at 37 °C in both cases). Unfortunately, the storage-stability of the 
biomass was not investigated. In another study (Koch et al., 2008), the same sce-
nario is repeated with Lactobacillus delbrueckii: lower pH – shorter cells – higher 
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freeze-dry survival but no storage-stability follow up. In that study, best freeze-
drying survival was after fermentation with uncontrolled pH which ended at pH 
3.4 and at the second place came the lowest controlled pH of 5. Interestingly, in 
the present study, the initial freeze-dry survival was likewise better at 37 °C, pH 
4.5 versus 32 °C, pH 6.5 (and overall best but not statistically significant, see Fig-
ure 11). In the present study, however, when it comes to storage-stability, the ta-
bles became turned and the higher pH treatment was best. Longer cells may be 
more susceptible to damage during freeze-drying (as well as simple freezing) as 
suggested in (Fonseca et al., 2000) and by the results of the present study’s FT-
assay and the abovementioned references, but the present study also showed that 
these longer cells seemed to have a big advantage in long-term storage (and per-
haps robustness), for reasons yet to be discussed. However, treatment B (32 °C pH 
4.5) which gave medium long cells had, in general, the worst storage-stability (see 
Table 16 below and Figure 11 in section 4.3), so there might be something else 
than cell size involved (although the difference in storage-stability between treat-
ments A (37 °C, pH 4.5)  and B (32 °C, pH 4.5) was not statistically significant). It 
would be very interesting to compare the current treatment C (32 °C, pH 46.5) 
with a treatment of 37 °C, pH 6.5 which combines a higher temperature with high-
er pH. 
In a third study (Schoug et al., 2008), Lactobacillus coryniformis was subjected 
to many different temperatures and pHs before freeze-drying. Best survival was 
observed when treated with optimal growth conditions (pH 5.5 and 34 °C) or by 
warm treatment (42 °C). Higher and lower pH gave lower survival. However, in 
that study, the fermentations were done at the optimal pH and temperature for cell 
yield and the “treatment” pH and temperature was applied first upon late logarith-
mic growth phase. Highest survival was linked to less unsaturation of fatty acids in 
cell membrane. Finally, a fourth study (Liu et al., 2014) performed in a similar 
fashion to the last one, L. reuteri I5007 was subjected to different temperatures 
and pHs before freeze-drying. This time, high temperatures (47 °C) or high pH 
(6.7) gave the best freeze-drying survival but there was no storage-stability inves-
tigation. In that study, the fermentations were also done at the optimal pH and 
temperature for cell yield and the “treatment” pH and temperature was applied 
first upon the stationary phase. In contrary to (Schoug et al., 2008), the higher 
survival was linked to higher levels of unsaturated fatty acids in the cell mem-
branes. Perhaps another local optimum was found, or it is a matter of difference 
between species. In the present study, the cell density before freeze-drying was not 
controlled as in (Schoug et al., 2008) and (Liu et al., 2014) because the special 
growth conditions were fixed throughout the cultivation. Because of this, the cell 
density factor was uncontrolled for and this factor has been shown to be significant 
for survival of Lactobacillus coryniformis in (Schoug et al., 2006) where higher 
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cell densities gave higher survival of freeze-drying. In the present study, treatment 
C (32 °C pH 6.5) coincided with highest cell densities out of the treatments tested 
(see Table 16) and as mentioned, correlated with better storage-stability but worse 
freezing survival. Because there was no storage assay in (Schoug et al., 2006), it is 
hard to draw a direct parallel to the first finding. At least a rational reason for the 
worse freezing survival of the elongated cells might lie in the large cell surface of 
elongated cells, leading to more damage from extracellular ice formation; also the 
small cell surface : cell volume ratio of elongated Lactobacilli affects the water 
flux from the cell and may promote intracellular ice formation (Fonseca et al., 
2000). One possible reason for the better storage-stability of cells from treatment 
C (32 °C pH 6.5) is that longer cells and higher cell densities increase Tc substan-
tially (Fonseca et al., 2004b) and since there were problems with collapsing (per-
haps even the non-collapsed batches were on the verge of collapse at the micro-
scopic scale), this could have been an advantage for these cells. However, this is 
contradicted by the fact that treatment B (32 °C pH 4.5) with medium long cells 
and medium cell density were the least storage-stable case, although more statisti-
cal power would be needed to confirm this relation. Perhaps the absence of cell 
clumps in treatment C (32 °C pH 6.5) was the main factor, or there are some deep-
er molecular causes for this result.      
Table 16. Summary of fermentation treatments and survival of freeze-drying (initial survival), freeze-
thaw (FT) assay and 1 week of accelerated storage assay, in relation to observed cell length and cell 
density of formulated L. reuteri before freeze-drying. For simplicity, the shown average values are 
not transformed or batch-adjusted 
Treatment Average 
initial 
survival 
Average 
FT-assay 
survival 
Average 
survival 
after 1 
week 
Average 
estimated 
cell 
length 
(µm) 
Average 
cell density 
of formu-
late 
(CFU/mL) 
95% confi-
dence interval 
(cell density) 
Sample 
size 
(cell densi-
ty) 
37 °C 
pH 4.5 
 
1.074 0.00903 0.125 2.1 2.03×109 ± 1.74×109 5 
32 °C 
pH 4.5 
 
0.559 0.05980 0.051 2.7 3.64×109 ± 1.74×109 5 
32 °C 
pH 6.5 
0.933 0.00017 0.456 6.1 6.45×109 ± 1.95×109 4 
 
The differences between initial survival ratios in the present study were far from 
statistically significant as the spread of individual measurements was large and this 
should be kept in mind. It is worrisome that while the grand adjusted means are in 
an almost reasonable range, one individual initial survival ratio is as high as 1.9 
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and another is 1.4. No ratios should be higher than one, anything else indicates cell 
growth, which would be unlikely. However, one theory is that this could be due to 
dissolving of cell clumps after freeze-drying (which was actually observed to some 
extent in microscopy, data not shown). However, the 1.4 initial survival ratio be-
longs to treatment C (32 °C, pH 6.5) which never had any cell clumps. Unfortu-
nately, this particular measurement belonged to batch 2 which was before micro-
scopic studies were applied so it cannot be confirmed whether there were no cell 
clumps. In future experiments, some anti-clumping agent could be considered for 
the before-freeze-drying VC. Perhaps a more likely explanation is that the proce-
dure for doing the before-freeze-drying VC was suboptimal and gave underesti-
mated starting cell counts. This can be suspected because the formulated biomass 
had to stand and wait during which all the freeze-drying vials were filled and put 
into the freezer and other laboratory tasks had to be done. The bacteria could have 
been damaged by floating around in a 15% sucrose-in-distilled-water solution for a 
long time (something that could be experimentally investigated). In such case, the 
relative difference between the initial survivals should still be valid, as all samples 
were subjected to similar procedures. 
7.4 Correlation experiment analysis 
The correlation between FT assay survival and stability in accelerated storage 
assay was mainly explored after 1 week of accelerated storage (Figures 13 and 
15). This choice of timepoint was based on several reasons; firstly, there were 
many biological replicates at that point (see Table 6). Secondly, there was a statis-
tically significant finding in the non-transformed, more easily interpreted dataset 
(Figure 11 A) while at the same time, it was a timepoint at which the samples had 
been exposed to accelerated storage for a substantial period. Additionally, both of 
the timepoints 1 week and 2 weeks have rather low coefficients of variation (CVs) 
in non-transformed values (see Table 6). It is important to remember that this cor-
relation may not apply to other formulations than 15% sucrose, will not apply to 
storage assays at different temperatures and that better avoidance of collapsing 
may change it too. 
The FT-assay survival correlates negatively with storage-stability, or more pre-
cisely, with the total CFU/mL after freeze-drying and accelerated storage. This 
includes the survival of a freeze-drying and a given time of storage. To really iso-
late the storage-stability itself, the reference CFU/mL value for calculating storage 
survival would have to be the CFU/mL after the freeze-drying and not (as done in 
this paper) the CFU/mL of the formulated biomass before freeze-drying. However, 
this was omitted due to lack of time. Since when it comes to surviving one freeze-
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drying (a freezing process involved), treatment A (37 °C, pH 4.5) was actually the 
best and treatment C (32 °C, pH 6.5) was the midst (although this was not signifi-
cant) which breaks the correlation seen in FT-survival (another freezing process) 
where treatment B (32 °C, pH 4.5) is the best and C (32 °C, pH 6.5) is the worst. 
This could, however, simply be due to random variation since the initial survival 
differences were not statistically significant. 
Although the correlation between the FT-assay and the accelerated storage sta-
bility assay is inverse, it does not exclude the use of FT-assay for storage-stability 
prediction; using the correlation equation will give a prediction assuming similar 
experimental conditions. However, it is important to make sure that the CFU/mL 
is acceptable before the FT-assay, otherwise a low FT-survival could simply mean 
that the bacteria were dead from the beginning.  
The inverse correlation lead the thoughts to the possibility that some (possibly 
cellular) factor makes the cells more resistant to freezing but at the same time less 
resistant to storage, and vice versa. This could be one factor but it could also de-
pend on two (or more) factors which could then perhaps be optimized inde-
pendently of each other to some extent, but happened to be confounded in this 
study by varying only pH and temperature. If there are many factors involved, a 
goal should be to identify these and design two assays, one which positively corre-
lates with high survival of the freeze-drying process and one which positively 
correlates with storage-stability. 
Further optimization of the freeze-drying of L. reuteri (by using factorial de-
signs) may hopefully lead to a recipe that assures both a relatively high freeze 
survival and storage-stability. In such case, the correlation equation found here 
will not be of much practical use but may at this point contribute to a wider under-
standing of the phenomena affecting freeze-dried bacteria.  
7.5 Statistics – experimental design 
As mentioned in the introduction, the original experimental plan looked differently 
than what was eventually done. The learning goal within the field of statistics was 
shifted from the cancelled formulation-screening experiment to the FT-
assay/accelerated storage assay correlation experiment and a big literature study 
was done to find a statistical strategy fit for the situation. This turned out to be a 
much more winding and strenuous path than expected, especially considering the 
collapses of some batches and the changing batch size. Ideally, a researcher should 
not look for statistical methods that fit to the collected data but instead plan the 
experimental design knowing that feasible statistical methods will be applicable to 
the data generated. In this case, it had to be the other way around to get hands on 
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with a little bit more advanced statistics and to actually make better use of the 
batch-wise scattered data. 
Paired t-tests were also considered when choosing the statistical method. How-
ever, using three paired t-tests to test the differences between the three treatments 
was not feasible because not all treatments were represented in each batch. There-
fore, in a batch-paired set of t-tests, the mean of treatment A, for example, would 
be different depending on if it was being compared with the mean of treatment B 
or C which would give inconsistent results and would be very awkward to present.  
The finally applied unbalanced RIBD was a “design of necessity”. All treat-
ments were paired (A paired with B, A paired with C and B paired with C) in 
blocks an equal number of times (except for timepoint 22 days which was lacking 
some data) and the sample size was equal for all treatments (again, except for 
timepoint 22 days). These are two out of three criteria for a balanced RIBD, how-
ever, the criterion of equal amount of treatments in each block (the third criterion) 
was not fulfilled since some of the early batches contained all three treatments 
while the rest contained only two treatments each. Excluding these larger batches 
would have given a balanced design but the sample size would become worryingly 
low; the homogeneity of variance would not be meaningful to assess and a lot of 
data would be wasted. Alternatively, after assessing the assumptions of ANOVA, 
the large batches could be excluded to get a balanced design while assuming that 
since the data is taken from the same populations, compliance with assumptions of 
ANOVA can still be assumed. This is however, left for the interested reader. There 
are ways to analyze block designs with unequal block sizes which are still called 
balanced (Gupta & Jones, 1983; John, 1998) but this was left out of the scope of 
this study. 
The variance was not split more than into treatments (as a fixed factor) and 
batches (as a random factor) for two reasons. Firstly, to split it further into indi-
vidual freeze-dry vials as a factor (or ”source of variation”) would require the use 
of a so called “nested/hierarchical” design (Miller & Miller, 2010) because the vial 
identity would never be replicated, each vial is unique and only used once. A nest-
ed design does not require all combinations of factors (such as the impossible sce-
nario of having vial no. x in all of batches no. a, b and c), instead they build on a 
hierarchic structure of factors and factors within factors. However, attempting a 
nested design did not seem worthwhile because of the dominating batch variation; 
separating the smaller sources of variation would not help. Furthermore, it would 
perhaps even be impossible since the design was already an incomplete unbal-
anced one and deeper studies of the nested design were omitted. It is obvious that 
batch number was the dominating nuisance variable and efforts should be done in 
future experiments to reduce this variance. Making two replications of the dilution 
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series and the plates may seem futile in the light of this; however, it was an action 
against outliers and possible gross mistakes. 
When it comes to the benefit of having used a block design, no formula was 
found for assessing this in RIBDs. The mean squares of the block factor were al-
most always greater than the mean square error, only the initial survival was an 
exception. However, to judge whether these ratios were high enough to consider 
blocking worthwhile would require more literature research. Compared to the 
mean square of the treatment factor, the block mean square could be much smaller, 
similar or larger in the many ANOVAs without any completely certain trend. 
When it comes to how the significance of the treatment effect was influenced by 
blocking, one-way ANOVAs without the block factor were run (results not 
shown). The initial survival non-transformed and the 2, 3 and 4 week log10-
transformed ANOVAs yielded increased significance of the treatment effect 
thanks to blocking while in the other cases the significance got lower. Perhaps the 
benefit of blocking was a border case in this experimental design. However, the 
ANOVAs run without also resulted in greater heterogeneity of residuals (especial-
ly residuals of treatment C had lower variance). Therefore, blocking could in this 
case have improved compliance with the statistical assumptions.  
Another aspect important to remember is that the log10-transformed analyses 
are not as straightforward in the practical interpretation as the non-transformed. 
The reason for this is not only that the geometric means must be used as the real-
world interpretation; it is also about the fulfillment of assumptions and the reliabil-
ity of the analysis. According to (Montgomery, 1991), when transformation is 
needed to get homogeneity of variance, the ANOVA will only be reliable in the 
transformed scale. Also, the coefficients of variation (CVs) examined in Table 7 
for log10-transformed data are valid only for the means of log10 transforms.  
As a final remark, regression methods (Altman & Krzywinski, 2015) for statis-
tical evaluation of the correlation between FT assay and accelerated storage assay 
itself, were not used due to lack of time for researching the methodology. 
7.6 Statistics – power 
No power analysis had been done before the study since this statistic approach was 
not planned. However, a power analysis can be done after the experiments too (in 
order to at least see what the power was, as long as the scientifically interesting 
difference has been predefined). It was attempted to make such a power analysis in 
G*Power 3 (Faul et al., 2007; Universität Düsseldorf: G*Power). However, it 
seemed like in G*Power 3, for a multifactorial ANOVA power analysis, each 
combination of factors must consist of at least two experimental repeats because 
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the “total sample size” must be larger than “number of groups”. Since each batch 
could only contain one of each treatment (at most), the requirement from the soft-
ware was not fulfilled. More literature research would be needed about how to 
analyze the power of block designs with only one replica of block-treatment com-
binations. Fortunately, having only one replicate per treatment in a batch seems to 
be a standard situation (Krzywinski & Altman, 2014a) so there must be plenty of 
software available for this situation. 
How big should effect size (see section 2.6 “Statistics”) be set for power analy-
sis prior to potential future experiments, if one would like to build upon the pre-
sent study? This will only be discussed in general terms, as it depends on many 
choices in the experimental plan. Firstly, it depends at what timepoint of accelerat-
ed storage one wants to do the measurements. It will also depend on whether log10-
transformation will be used. A sensible difference to detect could be one log10-
exponent. If no transformation will be applied, the difference between two non-
transformed means corresponding to one log10-exponent is going to become small-
er and smaller as the means get lower while the differences between transformed 
means would always be equal to one. For example, the difference between loga-
rithmized means -2 and -1 is 1 while 0.1 – 0.01 is 0.09 and the difference between 
-3 and -2 is 1 while 0.01 – 0.001 is 0.009. The choice of timepoint will also make 
the standard deviations of these means to change but not necessarily keep their 
proportions to the means unchanged. Therefore, the effect size corresponding to a 
difference of one log10-exponent will depend on chosen timepoint and transfor-
mation. Furthermore, it will depend on the general design of experiment such as 
blocking because the standard deviations may be estimated from a block adjusted 
or completely randomized design. Nevertheless, once these choices have been 
made, standard deviation data from this study may facilitate a proper choice of 
sample size. The effect size can be calculated and used in a power analysis soft-
ware to calculate the sample size needed for a specified statistical method, or the 
information can be used with tabulated “operating characteristic curves” (Mont-
gomery, 1991) to find the required sample size. As an example, consider that one 
is interested in measurements after 1 week of accelerated storage, with non-
transformed data and that an interesting difference between treatment group means 
would be one of 50%. Treatment C could be kept as a standard because it turned 
out to be so storage-stable; according to the present study it would have a mean 
survival ratio of (roughly approximating) 0.5 and a standard deviation of 0.24. 
However, this was the standard deviation of the unadjusted mean. The pooled 
standard deviation of the block adjusted means was 0.156 in this case (see Table 6) 
so this value could be used if it would be intended to do a block design. Since new 
fermentation treatments would probably be chosen in the successful high-pH area, 
a reasonable (and simple) assumption would be that these treatments would have a 
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similar standard deviation (otherwise the anticipated standard deviations must be 
pooled). 
For a multilevel ANOVA, an appropriate measure of effect size is Cohen’s f 
(Maher et al., 2013) according to equation (9): 
𝑓 =
√∑(𝑚𝑖 − ?̅?)
2
𝑘
𝜎
 
(9.) 
where k is the number of groups compared, mi is the mean of group i, ?̅? is the 
mean of group means and σ is the pooled standard deviation. The mean survival of 
treatment group C can from the results of the present study be entered as 0.5. If the 
difference of interest is 50%, another mean can be entered as 0.25. The third mean 
(if it is assumed that k=3 in this planned experiment too) can have an arbitrary but 
not more extreme value, for example 0.5 again. Calculating the mean of these 
means will yield ?̅? = (0.5 + 0.5 + 0.25) / 3 = 0.417 and σ can be guessed to stay at 
0.156. Entering these values will give f = 0.76. This is the effect size that can be 
used in a power analysis software once the statistical method/model has been cho-
sen (remembering that it must employ blocking because σ has been estimated in a 
block design).  
7.7 Microscopy 
Gram-staining unfortunately did not yield any conclusive results, since the results 
only correlated with batch number. Before implementing Gram-staining for L. 
reuteri in this study, a test session of Gram-staining was done with different bacte-
ria on the same objective and the results looked appropriately. However, there 
should have been reference bacteria sharing the objective with every subsequent L. 
reuteri sample to see if the stains were successful, as pointed out in (Smith & Hus-
sey, 2005). This source also pointed out that the samples for staining should better 
be thin but this was overlooked, however. Following this advice by diluting the 
samples could perhaps have given more consistent results. 
The suspected correlation of Gram-stain result with batch number could be ex-
plained by the medium quality and other batch-biased procedures. More specula-
tively, there could have been a procedural difference in how the Gram-stain was 
performed each time, although a strict protocol was followed. However, there 
could have been a difference in how effectively the microscopy plates were 
washed in running tap water for each batch during the steps of Gram-staining; it is 
important to do it delicately so that the sample is not washed away yet quickly to 
follow the protocol times.  
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As seen in panel “(C) batch 6” in Figure 29 in Appendix, there are quite many 
short cells present in this case, although at close inspection plenty of long cells can 
still be found. The large amount of short cells in this sample was surprising, since 
it belongs to treatment C (32 °C, pH 6.5) which in all other microscopy photos 
showed mostly medium to very long cells. An unstained sample from the same 
biomass can be seen in Figure 28, panel “(C) batch 6” in Appendix and it exhibits 
much more elongated cells. Perhaps the short cells were somehow up-concentrated 
in the Gram-stained sample during washing steps of the staining procedure. Any-
how, it would be best to repeat Gram-staining of a sample from treatment C. A 
small remark is that the cell size in photos of Gram-stained samples seemed over-
all smaller than in the non-stained microscopy images from Figure 18 in section 
4.7 and Figure 28 in Appendix. Either the staining procedure did shrink the cells 
or it improved the contrast allowing to see their true sizes.  
7.8 GASP 
What could be the reason behind that no obvious signs of GASPs were observed? 
Could the two mild “hills” in the heat flow during the long-term stationary phase 
(Figure 19 D and Figure 20 C) represent the activity of two subsequent GASP 
cultures? Why then, was this not observed in E. coli? At the time of doing the 
experiment, it was anticipated that the appearance of GASPs would be seen as 
obvious growth peaks reaching perhaps hundreds of µWs. Therefore, the experi-
ment seemed to be fruitless and not much VCs were taken. Filling in the missing 
VCs would greatly help to answer the questions and fortunately, this can be easily 
ameliorated by simple complementary experiments - a repetition of the cultiva-
tions with MOPS buffer and those with E. coli in the same conditions as previous-
ly but without any need of microcalorimetry.  
Nevertheless, many conclusions can already be drawn: since the heat-flow pat-
tern seemed very similar between non-buffered cultures (Figure 19 D) and MOPS-
buffered cultures (Figure 20 C), it did not look promising for the GASPs, since the 
cultures in non-buffered medium had died out (see Table 14).  
Furthermore, examining the literature more carefully provided some new in-
sights. Firstly, all previous GASP papers, which have a sufficiently detailed meth-
ods section to tell, describe cultivations with shaking and/or aeration (Zambrano et 
al., 1993; Finkel & Kolter, 1999; Smeulders et al., 1999; Vasi & Lenski, 1999; 
Bruno & Freitag, 2011). Supposedly there was an anaerobical cultivation too (with 
unknown shaking), in a PhD thesis which could not be retreated, referred to from 
(Zinser & Kolter, 2004). Neither shaking or efficient aeration was possible in the 
IMC, could this explain lack of GASPs in the E. coli control cultures? Assuming, 
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of course, that there was in fact a lack of GASPs, it is something to be checked 
with VCs (to begin with). Without shaking, the biomass formed a hard-to-dissolve 
plaque at the bottom of the ampoules. Perhaps all the nutrients needed for GASP 
growth were “locked” within this plaque? Without aeration, E. coli shifts to the 
heterofermentative “mixed-acid” pathway and produces acetic acid, lactic acid, 
succinic acid, ethanol, CO2 and H2 (Madigan & Brock, 2009). However, this is the 
case when fermenting glucose. The LB medium (also used in some of the success-
ful GASP studies) contains only small amounts of various sugars; instead amino 
acids are the main carbon source (Sezonov et al., 2007). As mentioned in the in-
troduction, amino acids seem to be of greatest importance also during the GASP 
growth. Evidently, E. coli does grow anaerobically in LB medium (Colón-
González et al., 2004). According to (Losen et al., 2004), when E. coli grows in 
unmodified LB-medium aerobically, it uses very low amounts of oxygen. The 
bacteria mainly use the amino acids as an energy source and therefore, the pH of 
such culture rises up to 8.7 (Losen et al., 2004). However, this rise in pH neither 
influences final OD or respiration. Adding buffer does not change anything except 
the pH and the growth limitation is therefore a limitation of carbon sources (Losen 
et al., 2004). All of these arguments point toward the hypothesis that the anaerobi-
city of the cultivations should not have influenced GASP evolution because if 
GASPs live off amino acids, they should cope with anaerobic conditions equally 
well as the original LB-broth cultivation, unless the anaerobic situation makes the 
pH climb even higher. What metabolic pathways are used when E. coli grows 
anaerobically on LB broth (amino acids) would need deeper studies. Furthermore, 
it is unfortunate that the E. coli inoculate used for the controls was not freshly out 
of a cell bank, but taken from the neighboring laboratories cultures. This could 
potentially mean that these E. coli had already gone into GASP formation before 
the start of the experiment. Also, it would have been best to make sure that the 
same E. coli strain was being used as in the classical GASP experiments.  
As a final remark, the theoretical detectability of GASP growth in IMC will be 
discussed. As already mentioned before, the total CFU/mL stays quite constant in 
the long-term stationary phase but with a dynamic interchange of living bacteria if 
GASPs appear. Looking at the CFU/mL values in the GASP literature, with E. 
coli, the highest cell count during a cultivation was about 5×109 CFU/mL and in 
long-term stationary phase it fell to about 5×107 CFU/mL (Finkel & Kolter, 1999). 
The values were roughly the same presented in (Finkel, 2006) and it was com-
mented that 99% of the cells died (two logs) in the passage from stationary phase 
to long-term stationary phase. With the Gram positive Listeria, there was roughly 
5×109 CFU/mL at the peak while it went down to 5×108 during long-term station-
ary phase, which means that the net decline in CFU/mL was only 90% (Bruno & 
Freitag, 2011). Even if the latter scenario is assumed, that 10% of the original cell 
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count must re-grow in the form of a GASP, this should roughly give off as much 
heat as 10% of the heat given off by the original growth phase. Furthermore, when 
the GASPs grow, the old cells must lyse and many of their components such as 
peptides and DNA must be hydrolyzed. The hydrolysis of polymers such as pep-
tides and nucleic acids is itself an exothermic process (Sturtevant, 1953; Arm-
strong et al., 1977) and would add up to the heat. Could some other endothermic 
process have cancelled out the heat-producing reactions of polymer hydrolysis and 
GASP growth? 
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8.1 Correlation experiment conclusions 
FT-assay survival correlated negatively with accelerated storage stability after 
freeze-drying (more precisely, with the total CFU/mL after freeze-drying and ac-
celerated storage). Highest pH during cultivation, highest cell density and longest 
cell length was associated with best storage-stability even among collapsed batch-
es (but lowest FT-assay and medium freeze-dry survival). However, the treatment 
which gave medium length cells and medium cell density was least stable (alt-
hough this was not statistically significant), so cell length and cell density were 
probably not the direct (or not the only) causes. Directly, high pH during cultiva-
tion seemed to be very beneficial as well as high temperature to a lesser extent. 
Furthermore, the most storage-stable treatment was also the only one lacking cell 
clumps, a factor worth further investigation. A combination of high pH and high 
temperature would be interesting for future investigations. Gram-stain appearance 
was inconsistent and correlated only with batch number. Better control procedures 
should have been applied during the Gram-staining.  
There are two possible future scenarios: if the initial survival and storage-
stability depend on exactly the same molecular factors and are confounded, then 
the equation proposed in the present study could be used as a predictor of product 
stability under the same experimental conditions. In the second scenario, if the 
tolerance to freezing can be improved independently of the accelerated storage-
stability, for example by changing formulation, controlling cell density or chang-
ing the freeze-drying process, then the correlation formula would become of low 
practical usefulness, except for shedding some light on the complex dependencies. 
If the second scenario is true, the FT-assay could be further investigated for testing 
the freeze-drying tolerance while another assay must be found which correlates 
independently with the storage-stability. Furthermore, future experiments could 
8 Conclusions 
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benefit from supplementing the MRS-medium with sucrose and fructooligosacha-
rides could be worth trying as the formulant.  
8.2 GASP experiment conclusions 
In conclusion, it seems unlikely that IMC is a feasible option for GASP detection, 
whether it is due to no possibility of agitation or to the cancelling out of endother-
mic and exothermic heat flows. To make sure however, a repetition of the anaero-
bic, non-agitated E. coli cultivations with VCs during long-term stationary phase 
could be done. If these cultivations maintain a GASP-like level of CFU/mL, then 
GASP detection with IMC can probably be ruled out. However, there are IMC 
systems with the possibility of stirring (Maskow et al., 2014). 
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Just as the ecosystems at land and sea are built upon complex interactions of a vast 
array of species, so are the hidden ecosystems of our own bodies. Science is barely 
beginning to scratch the surface of the interplay between species in our so called 
microbiota, but one thing is becoming clear – it has huge effects on our health. It is 
not surprising that probiotics, supplements of good bacteria, are becoming popular. 
Lactobacillus reuteri is one such bacterium available at the probiotic market and 
was the subject of this study. For probiotics to have any effects, however, they 
must stay alive for a long time in the form of tablets and powders. This is where 
the engineering comes in. One of the methods for preserving bacteria is freeze-
drying; an efficient method which allows further storage at ambient temperatures. 
Paradoxically, freeze-drying can become a lethal process for the bacteria if done 
arbitrarily. In fact, the whole manufacturing process, starting at cultivating the 
bacteria in bioreactors and ending at the dry bacterial powder, has to be properly 
optimized for each individual bacterial species if high survival rates and good 
storage-stability are to be achieved. There are different ways to optimize the 
freeze-drying survival and storage-stability of bacteria. One strategy, in focus of 
this study, is “preconditioning” done by subjecting the bacteria to different envi-
ronmental conditions during or after the cultivation, which alters their molecular 
expression and morphology. Another strategy can be to search for more robust 
mutants of the bacterium. A discovery made by other researchers related to this 
concern is that increasingly resilient mutants can be obtained from some bacterial 
species by over-fermenting the cultures for a long time. These mutants, referred to 
as “growth advantage in stationary phase mutants” (GASPs), take over the culture 
by scavenging the remains of their ancestors while themselves tolerating the scarce 
and polluted environment of an overgrown cultivation. Therefore, it was of interest 
whether such mutants could also be observed in L. reuteri. 
Since the overall goal of this study was to work towards finding the recipe for a 
more freeze-dry tolerant and storage-stable L. reuteri, both of the abovementioned 
strategies were applied. Firstly, it was investigated whether a quick assay could be 
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used to predict the freeze-drying survival and storage-stability instead of measur-
ing this directly by laborious viability measurements over many weeks, and the 
candidate of choice was a freeze-thaw assay. In the freeze-thaw assay, bacteria are 
subjected to several cycles of freezing and thawing after which their survival rates 
are measured. The survival of the freeze-thaw assay was then compared to the 
survival of conventional storage-stability measurements. The bacteria for this ex-
periment were cultivated at three different combinations of pH and temperature; 
therefore the experiment would simultaneously shed some light onto which culti-
vation conditions lead to the highest freeze-drying survival and storage-stability in 
general. Secondly, microscopic studies were applied to the abovementioned exper-
iment to see if the morphology of the cells could be linked with the freeze-drying 
survival and storage-stability. Finally, as a strategy towards finding more robust L. 
reuteri GASP mutants, batch cultivations were grown for a prolonged time in iso-
thermal microcalorimeters. These very sensitive pieces of equipment measure the 
heat given off by various processes, down to a few microwatts. It was hypothe-
sized that GASPs would be detectable by the heat released through their metabolic 
activity, since consecutive generations of GASPs mutants appear in a characteris-
tic wave-like manner.  
The results of this study showed that higher pH, and to lesser extent higher 
temperature, gave the best storage-stability. The differences in survival of the 
freeze-drying process itself were not statistically significant because there was a 
large spread in the data at this point of measurement. A correlation between stor-
age-stability and the freeze-thaw assay was found and it was inverse; a high stor-
age-stability meant low survival of the freeze-thaw assay and vice versa. There 
was no consistent link between morphology and storage-stability, although inter-
estingly, at highest pH the cells did not form any clumps in contrast to the other 
treatments. These results imply that the observed differences in freeze-thaw sur-
vival and storage-stability are caused by molecular changes in the cells due to the 
different cultivation conditions; something worth deeper studies in the future. 
When it comes to the quest for GASP mutants, no activity of interest could be 
observed; this either means that isothermal microcalorimetry is not a feasible tool 
for detecting GASPs or that L. reuteri (and E. coli controls) did not produce any 
GASP mutants. Overall, this study has hopefully lit up a path towards understand-
ing the phenomena which govern the fitness for freeze-drying preservation of L. 
reuteri.    
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Figure 23. Normal Q-Q plots of expected residuals for normal distribution versus observed standard-
ized residuals, for evaluation of the normality assumption of ANOVAs in the accelerated storage 
assay. Plots based on non-transformed (raw) and log10-transformed data are compared side by side. 
Each plot contains the combined residuals of all the biological replicates for all treatments and batch-
es at the given timepoint of accelerated storage (±1day), starting at the initial survival after freeze-
drying (“ini”) and ending at 1 week of storage. 
Appendix 
ini raw ini log 
3 day raw 3 day log 
1 week raw 1 week log 
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Figure 24. Normal Q-Q plots of expected residuals for normal distribution versus observed standard-
ized residuals, for evaluation of the normality assumption of ANOVAs in the accelerated storage 
assay. Plots based on non-transformed (raw) and log10-transformed data are compared side by side. 
Each plot contains the combined residuals of all the biological replicates for all treatments and batch-
es at the given timepoint of accelerated storage (±1day), in this figure starting at 2 weeks of; and 
ending at 4 week of storage. 
2 week raw 2 week log 
3 week raw 3 week log 
4 week raw 4 week log 
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Figure 25. Standardized residuals versus treatments, where treatment nr. 1 = 37 °C, pH 4.5; 2 = 32 
°C, pH 4.5; 3 = 32 °C, pH 6.5. From accelerated storage assay; timepoints (±1day) of storage starting 
at initial survival after freeze-dry (“ini”) to 1 week of storage. Comparison of non-transformed (raw) 
and log10-transformed data, respectively. Ratio of widest variance over narrowest variance is shown 
in the textboxes. 
ini raw ini log 
3 day raw 3 day log 
1 week raw 1week log 
1.9 
(better) 
1.2 
(better) 
2.2 2.1 
2.1 
2.4 
102 
 
  
  
  
Figure 26. Standardized residuals versus treatments, where treatment nr. 1 = 37 °C, pH 4.5; 2 = 32 
°C, pH 4.5; 3 = 32 °C, pH 6.5. From accelerated storage assay; timepoints (±1day) starting at 2 
weeks of storage and ending at 4 weeks. Comparison of non-transformed (raw) and log10-
transformed data, respectively. Ratio of widest variance over narrowest variance is shown in the 
textboxes. 
2 week raw 2 week log 
3 week raw 3 week log 
4 week raw 4 week log 
1.4  
(better) 
3.8 
1.7 
(better) 
5.0 
3.8 
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Figure 27. A = home lab microscope reference. B = course lab microscope reference. The big scale 
is the objective micrometer (10 µm between ticks) and the small scale is the ocular micrometer. 
Ocular micrometer was calculated to represent 0.79 µm between ticks at the home lab microscope 
and 0.99 µm between ticks at the course lab microscope. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
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Figure 28. Cultures of L. reuteri grown at three different fermentation treatments (A-C), examined at 
around harvest time. The blue rings help to spot cell clumps. Objective micrometers show the scale 
which is recalculated into µm using Figure 27 in Appendix. Viewed in phase-contrast microscopes at 
1000X magnification. See Table 11 for which microscope was used for each photo. Picture index: 
(A) 37 °C, pH 4.5; (B) 32 °C, pH 4.5; (C) 32 °C, pH 6.5. *Another photo of the sample in Figure 18 
B, here showing that very long cells were, albeit very rarely, found in this sample. 
 
 
(A) batch 4 
(B) batch 6 (B) batch 5* 
(B) batch 7  (C) batch 6 
(A) batch 7 
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Figure 29. Gram-stain of L. reuteri grown at three different fermentation treatments (A-C). Viewed 
in phase-contrast microscope at 1000X magnification. Objective micrometers show the scale which 
is recalculated into µm using Figure 27 B in Appendix (all photos are from the course lab micro-
scope). The blue arrows and a ring in the bottom left photo spot small groupings of lightly blue-
tinted cells (only some cells in the ring). Picture index: (A) 37 °C, pH 4.5; (B) 32 °C, pH 4.5; (C) 32 
°C, pH 6.5. 
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